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ABBREVIATIONS 
AP-1  Activator Protein -1 
AD Activation domain 
bZIP Basic leucine zipper 
bHLH Basic helix-loop-helix 
BCA Bicinchoninic acid assay 
CD Circular dichroism  
CDK Cyclin-dependent kinase  
DMEM Dulbecco's Modified Eagle Medium 
DTT      Dithiothreitol 
DBDs DNA binding domains  
ELISA   Enzyme-linked immunosorbent assay 
E2 Ubiquitin-carrier or conjugating enzyme  
E3 Ubiquitin ligase  
GDP Guanosine diphosphate 
GFP   Green fluorescent protein 
GST Glutathione S-transferase 
GOR Garnier-Osguthorpe-Robson  
GnHCl Guanidinium chloride or guanidine hydrochloride 
HD Huntington’s disease 
Hepes 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IDPs  Intrinsically disordered proteins 
IDRs Intrinsically disordered regions 
ID Intrinsically disordered  
IPTG Isopropyl β-D-thiogalactoside 
LM Linear motifs  
LZ Lucine zipper 
LB Luria Bertani 
MS   Mass spectrometry 
NES Nuclear export signal sequence 
NP40 Nonidet-P40 
NLS Nuclear localization signal sequence 
NaCl Sodium chloride 
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PBS Phosphate-buffered saline 
PyMOL Python-enhanced molecular  
PDB Protein Data Bank 
PMSF Phenylmethylsulfonyl fluoride 
RFU Relative fluorescence units 
RFP Red Fluorescent Protein 
RNAP II RNA polymerase II  
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SH Src homology 
SLiMs short linear motifs  
SUMO Small Ubiquitin-like Modifier 
TA Transactivating domains 
TRE 12-O-tetradecanoylphorbol-13-acetate (TPA) response element 
TR Transrepressing domain  
Tris-HCl Tris hydrochloride 
UD Ubiquitin-dependent   
UI Ubiquitin-independent  
VCA Verprolin, cofilin, acidic 
WASP  Wiskott–Aldrich syndrome protein 
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1. INTRODUCTION 
Proteins are biopolymers composed of 20 amino acids, which could be arranged in 
many ways to form a nearly infinite assortment of protein shapes. Researchers believed for a 
long part of the 20
th
 century that protein is eventually functional in the cell when folded into a 
well-defined tertiary structure. The view that protein sequence defines the 3D structure, 
which determines function, has been widely accepted. This relationship connects function to 
the primary sequence. At the same time however biophysical techniques used to characterize 
protein folding also indicated heterogeneous ensembles of conformations for functional 
proteins. It turns out that for some proteins, termed as intrinsically disordered (ID) proteins 
the native state is composed of a multitude of structures. Experimental studies and genomic 
analysis have been initiated to assess the occurrence and functions of ID protein segments 
1–5
. 
ID regions were found to be involved in intracellular signaling and regulatory processes, as 
well as interaction hubs for protein-protein interaction 
6
.  
Although structural evidence proliferated to demonstrate the existence of ID proteins 
in vitro, their cellular organization and role have remained quite enigmatic. An urgent matter 
has been raised how exposed regions of proteins can survive under cellular conditions.  
The proteasome system was well described for maintaining the protein turnover 
however; new mechanisms were predicted by which cells control intrinsically disordered 
proteins (IDPs) level within them. The process named “degradation by default” 7. Also 
described as ubiquitin independent pathway where the protein degradation is mediated by the 
20S proteasome core 
8. The ‘‘uncapped’ or free 20S particles are active in degradation of 
proteins that are either partly disordered or fully without prior modification, which makes this 
pathway a default or passive process which is unique to IDPs 
9, 10
. In 2009 a possible model 
has been put forward for how proteins with ID regions escape 20S proteasome degradation. 
Termed as the 'nanny' model 
7
, the ID proteins ('clients') have associated, protective partners 
('nannies'). The client-nanny interactions are weak, which - unlike chaperons - do not impose 
folding on the ID region, simply provides a shield from proteases or the proteasome. In this 
manner, nannies ensure the survival of newly synthesized IDPs. 
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In my thesis, we test the hypothesis that nannies control the levels of their ID clients 
using the AP-1 transcription complex as a model system. Here c-Fos is the ID client, which 
interacts with c-Jun serving as a nanny. We probed whether the interactions with c-Jun serve 
to regulate the turnover of c-Fos and therefore its function. We show c-Fos is a natural 
substrate of the degradation by default pathway, and complex formation with c-Fos has a 
protective role. Furthermore, we explore the nature of interactions between these two proteins 
and their coorelation in terms of protein turnover. Based on the availability of similar 
complexes, we propose that the nanny model could be a wide-spread phenomenon to rescue 
ID proteins. 
1.1. Background of intrinsically disordered proteins 
Intrinsically disordered proteins (IDPs) contain regions, which are devoid of a well-
defined tertiary structure 
4, 2
. These could be  loop and linkers in a large folded protein or may 
affect a larger portion of a protein 
11
. Intrinsically disordered regions (IDRs) usually defined 
by continuous stretches ≥ 30 amino acids.  
 A number of additional terms have been used to indicate the highly dynamical or 
polymorphic characteristics of these proteins, such as natively denatured 
12
, natively unfolded 
13
, intrinsically unstructured 
14
, intrinsically denatured 
12
, intrinsically unfolded 
13
, 
intrinsically disordered 
4
, floppy 
15
, flexible 
16
, mobile 
17
, partially folded 
18
, vulnerable 
19
, 
malleable 
20
, dancing protein 
21
.  
A number of structural and functional aspects of IDPs are distinct from folded 
proteins. A strong amino acid compositional bias in IDPs, i.e. abundance of hydrophilic and 
charged residues and lack of hydrophobic core is responsible for their lack of structure 
22–26
. 
Their existence in vitro has been reported with many state-of-the-art solution state-NMR, 
small-angle X-ray scattering and fluorescence spectroscopy, circular dichroism (CD), and 
single molecule fluorescence resonance energy transfer (smFRET) measurements 
27-33
. 
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Figure 1. Example of intrinsically disordered proteins based on their degree of disorder. The figure is 
adopted and modified from 
11
.   
1.2 Emergence of a new paradigm 
In general, evolution has produced increasingly complex organization and complexity 
is one of the fundamental indexes of evolution. Proteins are also the results of evolution.  In 
the vastness of the protein sequence space available, Nature has extremely narrowed its 
evolution-driven search 
34
. The potential amino acid sequence in the protein that would 
aggregate under generic physiological conditions is generally eliminated by evolution. As a 
result, only a few selected populations get its place in this large amino acid sequence space.  
The first large fraction of selected amino acid sequences from globular protein where 
the amino acid sequence adopted a folded structure with the ability to perform function, 
which could thus be selected by evolution. Ultimately, these proteins were easy to purify and 
crystallize and get faster recognition in the field of structural biology. Up to experimental 
confirmation of structure–function relationship (structure-function paradigm) 35 with 
Anfinsen’s Rnase A demonstration of folding from unfolded state to achieve its functionality 
36
 . Undeniably, it helped to dominance the idea a well-behaved protein was synonymous 
with well-structured, with one singular function, and one mechanism of action. 
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Figure 2. Classical structural biology is based on deterministic sequence-structure-function 
relationships. 
Another evolutionary region of the amino acid sequence space is that of protein that 
lack constraints on maintaining packing interactions (neither aggregates nor collapse, still 
functional). These are known as intrinsically disordered proteins/regions. IDRs typically 
evolve faster than structural domains. These groups of protein residues display a wide range 
of evolutionary rates, depends on flexible, constrained and non-conserved disorder 
37
. 
However, IDPs were initially regarded as a bit of an oddity. The failure to experimentally 
prove became a problem and eventually led to the ignorance of this protein class. Later, these 
anomalies accumulated over the years to the point where could no longer be neglect. The 
different definitions of IDPs emphasized not only the need of a new structure-function 
paradigm, but also new computational and experimental approaches to deal with them in 
depth.  
More detailing of IDPs with respect to their different behaviors and functions doesn’t 
place them against globular proteins, instead might place both of them at different points on a 
continuum. For example: like ordered proteins, the disordered proteins are common to all 
living organisms 
5, 38, 39
, are essentially important for basic cellular performance. Both states 
of protein in terms of their folding have movement at the atomic level and well fit their 
Ramachandran angles. In fact, the same building blocks - the 20 amino acids control 
structural and functional preferences-and the same laws of physics apply in both cases. 
1.3 Prevalent features of IDPs 
Different definitions of IDPs described them as having little or no ordered secondary 
or tertiary structure, in contrast to properties of ordered proteins. Their experimental 
properties are at odd with those of ordered proteins to the extent that these can be taken as 
indicators of disorder. Examples are enhanced sensitive behavior to proteolysis 
40–42
, residues 
12 
 
missing from electron density maps 
43, 44
, absence of secondary structure or negative values 
for 1H-15N heteronuclear NOEs in NMR spectroscopy, low intensity peaks from ~210 to 
~240nm in circular dichroism and larger Stoke’s radius than expected hydrodynamic 
dimensions.  
There are several signs and scores to define disorder in a protein, however, not 
necessarily all features are mandatory to be present in each IDPs. They can be present to 
different extent in a system-dependent manner. Here, we will discuss very prevalent features 
of IDPs as an indicator of structural disorder. 
1.3.1 Sequence 
Compared to sequences from ordered proteins, the compositional trait of IDPs/IDRs 
is the low portion of bulky hydrophobic (Ile,Val and Leu,) and aromatic (Trp, Phe and Tyr,) 
groups, considered as ‘ordering’ amino acids 45. By contrast, IDPs are constantly enriched in 
polar (Gly, Arg, Ser, Gln, Pro, Lys and Glu) and structure-breaking amino acid residues like 
Pro and Gly considered as a source of disorder 
4,
 
46, 24,
 
47
. These biases in amino acid 
composition in IDPs enabled a coarse prediction of disorder from primary sequence 
information alone via a numerous developed disorder predictors 
48-50
. It was moreover 
revealed that IDRs and low complexity sequences have similar compositional bias – less 
order-promoting residues (C,W,Y, I and V) in comparison to more disorder-promoting 
residues (R, K, E, P, and S) 
24
. Groups of functionally related proteins were found to have 
similar disorder–complexity distributions within each of the group but reported to show 
notable differences between groups 
51
. 
The long disordered regions in proteins exhibit a close relationship with low sequence 
complexity. The length of IDRs observed to be one of the structural related function indicator 
of disorder, emphasized that length of IDRs follows a power law distribution in human 
proteome 
52
. Proteomic studies from eukaryotes and prokaryotes revealed to have similar 
disorder length profiles which were shown to be advantageous for cell functionality 
53
. 44% 
of human protein coding genes have been reported to contain IDRs having >30 amino acids 
in length. However, the IDRs with different lengths have been shown to exhibit distinct types 
13 
 
of IDP functions. The frequently occurring short IDRs may be short linkers or linear motifs 
54-56
 conferring binding or post-translational modification. Longer ones may be longer linkers, 
a combination of motifs, or domains functioning in recognition or as entropic chains 
56
.  For 
example: transcription mediated functions are usually over-represented with long disordered 
regions which are typically more than 500 residues. Similarly, IDRs containing regions of 
intermediate length like 300-500 residues are enriched for kinase and phosphatase functions. 
Furthermore, short IDRs which are less than 50 residues tend to be linked to GTPase 
regulatory functions and metal ion binding, ion channel. Thus, the length of a IDR can be a 
determinant and provide a useful indication about the function of the protein containing it 
53
. 
1.3.2 Conformational ensembles of IDPs  
The adequate representation of single fixed conformation of a protein would fit to the 
“lock and key” theory 57 in which protein exists in a single well-defined state biased for the 
optimal ligand. Emil Fischer who laid this idea assumed that the interaction between a 
specific protein and its substrate take place only in case of a steric complementarity of protein 
crevice/binding surface and the substrate.  
Later in the following years, ordered proteins were shown to exhibit a well-defined 
minimum energy states (one or few favored conformers) in a rugged energy landscape which 
means they are not fully rigid, they do possess some sort of flexibility and go through many 
unfavorable states that eventually collapse via multiple routes into possibly favorable folded 
state. Protein folding is therefore described as a conformational funnel 
58
. Eventually, ordered 
protein achieves a unique equilibrium configuration.  
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Figure 3. Free energy associated between intrinsically disordered proteins and globular proteins. The 
figure is adopted and modified from 
59
. 
In contrast, IDPs are continuously fluctuating between multitudes of conformations 
states (collection of structurally similar and nearly energetically equivalent conformations of 
the protein) and rugged free energy landscape. Barriers between the wells of the landscape 
are comparable to kBT (kB is the Boltzmann constant and T is the temperature). Therefore, 
IDPs exhibit high conformational entropy in the free state, as compared to folded proteins. 
This raises a problem regarding IDP interactions: binding could be accompanied by a large 
entropy loss ('entropic penalty') 
59
.  
1.3.3 Protein interactions by intrinsically disordered proteins  
Another unique feature of intrinsically disordered proteins is their binding 
promiscuity which means the ability of one partner to bind to many partners 
60
. In contrast to 
ordered proteins, IDPs are highly pliable and one IDP can form an array of unrelated 
structures being bound to different partner 
61
. Many IDPs, being mostly disordered, tend to 
have transient elements containing preformed secondary structure which are highly 
interaction prone and used for binding to specific partners with high specificity while 
retaining low affinity with the help of IDRs 
62
. Intrinsic disorder in a protein could allow one 
protein to bind with multiple partners (one-to-many signaling) or to enable multiple partners 
to bind to one protein (many-to-one signaling) 
38
. For example, the kinase inhibitory domain 
15 
 
of the cyclin-dependent kinase (CDK) inhibitor p21
Cip1 
which can bind to a diverse family of 
cyclin–CDK complexes 30. Similarly, the GTPase-binding domain of the Wiskott–Aldrich 
syndrome protein (WASP) able to bind to its own C-terminal of VCA (Verprolin, cofilin, 
acidic)  domain, which results in auto-inhibition, whereas in an altered conformation it bind 
to the GTPase Cdc42, results in initiation of actin polymerization through WASP activation 
63
. 
There are several other structural properties of IDPs for example position of 
disordered regions, percentage of disorder present in a protein, tandem repeats required for 
normal cellular function and prone to cause aggregation.  The general descriptions of each 
property will be discussed throughout the thesis in the sub-sections, so I will not make a 
detailed comparative discussion here. However, interested reader can find detailed 
information in these interesting articles 
25, 26, 37, 53, 64, 65
. 
Last, but not least, unique features of IDPs include folding upon binding, 
conformational selection, formation of fuzzy complexes with their interacting partner. I will 
discuss these particularly interesting features of IDPs in the section Binding mechanisms of 
IDPs. 
1.4. Binding mechanisms of IDPs 
One of the most intriguing aspects of IDPs in order to perform their function is their 
ability to undergo disorder-to-order transitions upon binding 
66, 67
. Adoption of the right 
conformation by the substrate taking place upon binding has garnered lot of attention in the 
field of structural biology. Although, the intermolecular interaction involving IDPs have 
divergent views on their binding mechanisms. Two main mechanisms for the interactions of 
disordered proteins gained popularity in the IDPs field: conformational selection and induced 
folding 
68
. 
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Figure 4. Schematic representation of the different binding modes observed for IDPs interactions 
(shown in blue) with folded proteins (yellow). In the “conformational selection” the folded binding 
partner bind to a specific conformation of the ensemble, which can also be a folded state. In the 
“induced-fit”, the presence of the binding partner induces folding of the IDP. In the multivalent fuzzy 
complex, binding mode, remain disordered with alter native conformations reflecting different 
binding mechanisms. The figure is adopted and modified from 
69
. 
The structural adaptability of ID proteins is studied extensively in numerous 
regulatory pathways, signaling, gene expression and cell-cycle regulation 
70, 71
. ID proteins 
mechanisms are based on their interaction with DNA, RNA, small metabolites and their 
protein partners. As ID proteins lack stable tertiary structure in their free native forms, arise 
many thoughts regarding their interactions and specificity of these interactions. The first 
mechanism was termed coupled folding binding, where ID proteins lose its conformational 
heterogeneity in comparison to its native state 
72
. This proposal has limitation as it couldn’t 
differentiate the conformational diversity of free form/bound form of intrinsically disordered 
protein and assumed to achieve stable well-defined structure in the bound form 
2, 38
.  
The factors like the low affinity, entropy loss governs the binding and folding of ID 
proteins interactions. To understand the broad range of IDPs’ characteristics requires a 
comparison of ID proteins ensembles in their free native forms to their bound forms. 
17 
 
Emerging computational and experimental data suggested that ID may possess pre-organized 
secondary structures and may not be totally random in its free state 
73, 74
. Following similar 
lines, the conformational selection mechanism was suggested, where the ligand (or target 
protein) selects among the conformations of the dynamically fluctuating protein and shifts the 
conformational ensemble which is compatible with binding. Hence, this model proposed the 
pre-existence of inter-converting conformations folds before binding to the partner shift the 
population to specific bound state. It was further noted that structural centric changes are not 
only dependent on protein itself, rather also on surrounding environment 
72
.  
An alternate binding mechanism, which is also referred as ‘binding–induced folding’ 
also emerged. It proposed that the disordered protein undergoes a disorder-to-order transition 
process upon binding to their partner. This illuminates that folding does not occur until the 
IDP has interacted with the target protein. A shift can occur from one conformational state to 
another upon binding third partner or upon post-translational modifications such as 
phosphorylation or alternative splicing 
72
. An important example of this is the increase in 
binding affinity by five-fold of the tumour suppressor p53 TRD to the KIX domain of the co-
regulator CBP/p300 upon phosphorylation 
75
. 
Finally, experiments and computational analysis revealed the commonness of both the 
events governing molecular recognition by IDPs. It turns out that the most often, folding 
coupled binding and induced folding work in synergy. Perhaps, their contribution to the full 
binding mechanism will be dependent on the binding rate required, IDP’s concentration, the 
native local plasticity of IDPs and many more other disorder to order transition factors.  
Eventually, increased appreciation of preformed structural elements proposal budded 
an interesting observation. In contrast to previous mechanisms, sequences of ID regions in 
their free state as well as in their bound state predicted to fall outside the allowed regions of 
the Ramachandran map, possibly suggesting disorder to disorder transition even in 
complexes. This phenomenon termed ‘fuzziness’ represents the extension of the paradigm of 
structural disorder to the functional-bound-state 
76, 77
. I will discuss this detail in the 
following section. 
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1.5 Physiological roles of IDPs  
The intrinsically disordered protein field has been immensely expanded in the last 20 
years; now considered as a new branch of unstructured biology. Since the late-90’s, more 
experimental data’s of intrinsic disorder in relevant proteins started accumulating with 
respect to their role in cellular signaling and human disease. Few prime examples includes 
studies of tau, ataxin-1, α-synuclein and huntingtin in several neurodegenerative disease 78, 
similarly the correlation of the expression of the IDPs Stathmin and p27 to various type of 
cancer 
79, 80
.  
In general, IDPs seem to be more prevalent in signaling pathways, cell cycle 
regulation, transcriptional and translation regulation 
71
. Target selectivity and fast 
association/dissociation rate in protein-protein interactions are highly specific in IDPs 
molecular recognition functions 
81
. The most common functional interactors within IDR 
sequence are the linear motifs (LM) also known as short linear motifs (SLiMs) or molecular 
recognition features (MoRFs) 
55, 82–85
. These short sequences ranging from 3 to 70 amino 
acids and more are the providers of both selective specificity and promiscuous multivalency 
in intrinsically disordered proteins 
86
. Recently, it was proposed that linear motifs in IDR in 
synergy with folded domain regulate formation of higher order assemblies 
87
. The role of 
interaction motif’s functions and regulation of protein assemblies through post-translational 
modification brings important advantages to the signaling processes 
71
. Sites of post- 
translational modifications are commonly present in IDRs 
88
 and important for modulating 
the binding activity of numerous proteins in signaling networks. The properties like 
flexibility and conformational dynamics of intrinsically disordered proteins increased their 
accessibility for post-translational modification 
89
. Signaling can be regulated by sequential 
modification of multiple phosphorylation sites or by the removal (or addition) of single 
phosphoryl group, can give rise to range of signaling responses 
89
.  
Therefore, multifunctionality, plasticity, dynamic tunability and modulations via post-
translational modification are undoubtly advantageous in the context of complex cellular 
networking. 
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The precise control to maintain right endogenous amounts of IDPs and the integrity of 
the associated signaling and regulatory mechanisms is crucial for cell’s normal cellular 
function 
90
. Availability of IDPs is controlled by multiple mechanisms during transcription 
and translation, especially of those IDPs which are present at low levels or have shorter life-
times 
91
. These signify that IDPs are precisely and tightly regulated from transcript synthesis 
to degradation 
90
.  
The regulation of the susceptibility of IDRs to proteasomal degradation is an 
important topic of the thesis. In the following sub-section I will thus discuss the mechanisms 
of protein degradation emphasizing on IDRs and their precise regulation mediated by 
proteasomal degradation.   
1.6 IDPs in disease 
Formerly, protein function deranging effects of missense mutations were interpreted 
in terms of destabilization and perturbation of structured elements. Later it was realized that 
mutations in IDRs can equally be deleterious by affecting dynamics, causing disorder-to-
order transitions or altering MoRFs. 
What is special about IDPs and makes them cardinal players in the development of 
pathological conditions is their unique, high specificity, low affinity interaction capabilities 
and interactions entailing transient context dependent many-to-one and one-to-many 
associations (binding plasticity and binding promiscuity) in signaling networks. Indeed, 
signaling networks in eukaryotes are highly enriched in ID proteins 
11, 56
. 66% of cell-
signaling related proteins were predicted to contain disordered regions of >30 residues, which 
is significantly higher than the prevalence of disorder in eukaryotic proteins in general (47%) 
92
. It follows from the high prevalence of IDPs in homeostatic regulation that aberrant 
regulation of IDPs at different levels likely results in the development of various pathologies. 
These different levels include genetic alterations, such as mutations, chromosomal 
translocation, aberrant splicing, incorrect alternative splicing, and non-genetic ones, as levels 
of protein expression and availability, cleavage propensity, and post-translational 
modifications or disrupted trafficking. 
20 
 
It is directly pertinent to the subject of my dissertation, that for the purpose of 
physiological regulation of biological processes it is crucial that a given protein be available 
in appropriate amounts and not to be present longer than needed, IDR-containing proteins 
have to be tightly regulated and controlled. IDP encoding mRNAs have accelerated decay 
rates, lower rates of IDP protein synthesis, and shorter half-lives 
91
. 
Misregulation of IDPs have been linked to many human diseases. Any such 
aberrations were shown to be directly responsible for the pathogenesis includes types of 
cancer (p53, BRCA1), neurodegenerative diseases (α-synuclein, tau, β-amyloid), 
cardiovascular disease (hirudin and thrombin, LDLR) 
93
, AIDS (HIV Rev protein) 
94
, cystic 
fibrosis (CFTR) 
95
, developmental disease and certain viral infections.  
1.6.1 Cancer 
It was predicted that 79% of cancer-associated proteins contain disordered regions 
which are >30 residues long 
92
. For example: 
p53 
p53 function is inactivated in numerous tumors famous ones like colon, lung, breast, 
liver, brain, hemopoietic tumors and many more due to mutations or abberations in regulatory 
process 
96
. p53 has promiscuous behaviour with multiple binding proteins to carry out various 
signal transduction function. Several of these are transcription factors, and activators/ 
inhibitors of its transactivating function. The N-terminal transactivation domain, the C-
terminal regulatory domain, and the DNA binding domain (DBD) of p53 are the determinant 
for these effects on cellular level 
97, 98
. However, the terminal domains contain disordered 
regions which are responsible to mediate and modulate interactions with other proteins. 
Roughly ∼70% of p53 interactions are mediated by IDRs and a multitude of PTMs in the 
disordered regions (acetylation, phosphorylation, and protein conjugation) are involved in 
their regulation  
99
 mutations of which can lead directly by disrupting interaction motifs or 
any perturbation of the dynamics of the disordered segments to aberrant function of p53 and 
cellular transformation.   
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As another example: BRCA-1  
More than half of the BRCA1 residues are predicted to be disordered 
99
. Surprisingly, 
BRCA1 binds to multiple proteins including in DNA damage sensors, DNA repair factors, 
transcription factors and signal transducers 
100, 101
. The vast majority of these occur through 
dynamic interactions with the IDR, mutations of which are often linked to breast and ovarian 
epithelial cancer. 
Besides constituting heterogenous interactions regions that can be perturbed by point 
mutations, structural disorder of connecting segments between structured domains confers 
viability on oncogenic fusion proteins, as translocation breakpoints need to be mostly located 
in the disordered regions or motifs, result in functional proteins. Consequently, IDRs are 
significantly enriched in oncoproteins arising from chromosomal translocations 
102
. 
Translocation-generated fusions through flexible disordered peptide segments enable the 
long-range structural communication of binding and catalytic domains (BCR-ABL, BCR-
RET) or kinase and dimerization domains 
103
.  
1.6.2 Neurodegenerative disorder  
Besides membrane bound organelles, cells harbor organelles that are ’membraneless’ 
in the sense that they are not surrounded by a membrane. These supramolecular assemblies 
are usually composed of nucleic acids, proteins and other molecular components. Examples 
include the nucleolus, nuclear speckles, stress granules (SGs), processing bodies, and the 
centriole 
104, 105
. Early studies already pointed out their dynamic nature and fluid-like 
properties as much as they fuse, separate and their components retain their movement and 
mix. We have recently come to understand the physical process by which is formed, which 
has been called phase separation or liquid-liquid demixing. The missense mutations in a 
number of low-complexity IDR containing stress granule proteins (hnRNPA1, FUS, TDP-43) 
cause neurodegenerative disorders such as ALS, where both mutant and wild type proteins 
are found to be aggregated in neurons 
106, 107
. However SGs are assemblies which are 
dynamic in nature, have a fibrillar architecture aggregates 
108, 109
. These disordered domains 
can form reversible hydrogels, and this is dependent on labile kinked β sheets 110, 111. In liquid 
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droplets, the low-complexity domains retain their tendency to be disordered 
114, 115
. However, 
with time an eventual maturation into fibrillar solid aggregates occurs, the rate of which is 
enhanced by ALS-causing mutations 
112, 116
. Both the labile-to-stable gel 
113
 and liquid-to-
solid 
112, 116
 transitions could explain the pathological conversion of SGs to aggregates in for 
ALS 
117
. 
1.6.3 Aggregates 
While IDPs contain regions that are functional in their unstructured state, many other 
proteins are known to unfold or misfold and they need to be either refolded by chaperones or 
to be removed by the proteasome or by autophagy. Often such misfolding occurs at such a 
scale that the protein degradation machinery is overwhelmed and the proteostasis of the cell 
is perturbed. The accumulating misfolded proteins tend to aggregate and/or sequester the 
protein quality control machinery exhausting the cell’s capabilities to recover. This leads to 
several human diseases that originate from the deposition of protein aggregates formed from 
specific proteins or protein fragments in number of tissues 
127–129
.  
For example: Missense mutations in human succinate dehydrogenase increases 
turnover rates and have been associated to play a crucial role in neuroendocrine tumors 
130
.  
Another interesting example is of α-synuclein which constitutes ~1% of the total soluble 
protein in the brain and reported to present in the cells for longer period of time via multiple 
interactions or PTM modulations which promotes aggregation and lead to disease 
131
.   
1.6.4 Viral assemblies 
IDPs are important structural and functional components of paramyxoviruses, e.g. the 
measles virus (MeV), the Sindai virus and the newly emerged Nipah and Hendra (NiV and 
HeV) viruses, which cause 
118
 zoonoses associated with severe and often fatal encephalitis   
119
. Paramyxoviruses are encapsidated by the N nucleoprotein. N proteins are over 500 
residues long and consist of a globular N-terminal domain, NCORE, which is crucial for the 
formation of self-assembly, RNA-binding, and of a C-terminal domain, NTAIL. The NTAIL 
domain is disordered shows low sequence conservation with a compositional bias for polar 
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and charged residues and against hydrophobic residues. NTAIL is exposed at the surface of the 
viral nucleocapsid and establishes a fuzzy interaction with the P phosphoprotein of the RNA-
dependent RNA polymerase of the virus during viral infection once the viral 
ribonucleoprotein has been released into the cytoplasm of the infected cell and transcription 
of viral genes starts. P is an essential polymerase cofactor since it allows the large subunit of 
the polymerase to be recruited onto the nucleocapsid template triggering transcription and 
replication 
120–123
. Hence, the NTAIL–P interaction needs to be dynamically established and 
broken to ensure RNA synthesis. The affinity of the NTAIL–P interaction is critical for viral 
transcription rates 
125
. The NTAIL–P interaction strength has to be kept into a precise window 
to ensure efficient transcription and replication. The dynamic binding of the complex 
provides the means to modulate the binding affinity 
126
. 
1.7 Proteasomal degradation  
 The proteasome is a large assembly of proteins (2.5 MDa in size), it consists of two 
major entities: the 20S catalytic core and the 19S regulatory particle(s) (RP). The 19S RPs is 
composed of multiple subunits of proteins with molecular masses ranging from 10 kDa to 
110 kDa, and is also designated as PA700. The 19S regulatory particle generally associates 
with one or both ends of 20S proteasome core in order to recognize ubiquitin tagged proteins 
and for their translocation into the interior of the 20S catalytic core. The 20S core, which on 
its own is also called 20S proteasome, is a cylinder like structure with a molecular mass of 
approximately 750 kDa, packed together from outer α rings and inner β rings. In other words, 
the catalytic core of the proteasome is a particle, which consists of seven α and β structurally 
similar subunits arranged in axial stacking style. Each inner ring which is consisting of three 
β-type subunits is associated with catalytically active threonine residue at their N-terminal 
and possesses N-terminal nucleophile hydrolase activity. These β subunits (β1, β2 and β5) are 
linked with caspase-like/PGPH (peptidylglutamyl-peptide hydrolyzing), trypsin-like and 
chymotrypsin-like activities respectively. The enzymatic activities help the proteasome β-
subunits to cleave peptide bonds present at the C-terminal or at the side of basic, acidic and 
hydrophobic amino-acid residues 
132
. In the resolved crystal structure of the 20S proteasome, 
the center of the outer α ring is completely closed and it prevents internalization of proteins 
into the inner β subunit (proteolytic active site). In addition, N termini of the α subunits form 
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a physical barrier, which further restrict the access of proteins to the active sites. Thus, client 
proteins are only allowed after passing the narrow opening situated at the centre of the α rings 
133
. 
Protein degradation plays role in almost every basic cellular regulation. Two 
alternative proteasomal degradation mechanisms have been described for IDPs: ubiquitin-
dependent (UD) degradation and ubiquitin-independent (UI) degradation which are not 
mutually exclusive. These mechanisms are keys to maintain protein half-life in cells 
135, 136
. 
 
Figure 5. Structure of the Proteasome. The figure is adopted and modified from 134. 
Many proteins in the cell are selectively degraded via the ubiquitin-26S proteasomal 
degradation pathway 
137, 138
. The labelling step is an active process, performed on the 
substrate (IDPs or otherwise) in a highly regulated three step sequence during which 
ubiquitin, a 76 amino acid protein becomes covalently conjugated to the substrate protein 
making it for 26S proteasomal degradation. Structurally, ubiquitination is catalyzed by three 
proteins: the ubiquitin activating enzyme (E1), the ubiquitin-carrier or conjugating enzyme 
(E2), and the ubiquitin ligase (E3). In brief, the E1 enzyme stage 1 is ATP driven process and 
activation of Ub is the main goal which then transfer to another stage 2 E2 carrier enzymes, 
where formation of Ub-carrier enzymes E2 convert into an intermediate (E2-S-Ub). The stage 
1 and stage 2, in combination with one of many E3 ubiquitin ligases, transfer the ubiquitin 
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monomer to the substrate. There are two main classes of E3 ligases which show difference in 
attaching Ub to the substrate. In the case of RING-domain-containing ligases, Ub is directly 
delivered to the subtrate however in some cases like HECT-domain containing ligases, 
dilvered after formation of intermediate (E3-s-Ub) 
139
.  
First, the C-terminal of ubiquitin, forms an isopeptide bond with the amino-acid group 
of a Lys in the substrate 
140
. The ubiquitin attachment can then be extended in a polyubiquitin 
chain through one of sever lysines in ubiquitin. For proteasomal recognition, as a minimal 
signal a chain of four Ub molecules need to be sequentially connected to through Lys48 
linkages to the target protein 
141, 142
.  
Recently, exciting discoveries in the field have revealed the susceptibility of proteins 
(mostly protein of inherent disorder) to ubiquitin-independent degradation which is mediated 
via the core 20S proteasome 
10
. In contrast to UD, UI degradation is a passive process where 
the ‘uncapped’ or ‘free’ 20S particles are active in degradation of substrates that are either 
completely or regionally disordered in nature without prior modification of the substrates. It 
is also referred as ‘degradation by default’. Thus, IDPs have different fate of degradation than 
the globular proteins in order to regulate them in vivo. The author also mentioned the 
possibilities why no significant correlation were observed between intrinsic protein disorder 
and shorter half-lives in the literature, by emphasizing on the existence of protective 
mechanisms of ‘default degradation’ 143. 
Structurally, the design of the proteasome suggests that the entry gates of the 20S 
proteasome are too small for correctly folded globular proteins in their ‘native’ conformation 
and the substrate should be denatured by the regulatory 19S subunit prior to 20S degradation 
144, 145. However, IDPs override this requirement. For example, p21 and α-synuclein which 
are directly susceptible to uncapped 20S proteasomal degradation due to their inherent 
disorder behavior 
146,
 
147
. However, it is not true in all the proteins, as certain motifs proved to 
be resistant to degradation as was reported for the polyQ chain 
148
.  
Previously, it has been estimated that long IDRs contribute 36-63% of the eukaryotic 
proteomes in vitro studies 
3
. Other findings confirmed that IDPs form functional complexes 
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in vivo and this might be the reason why IDPs to escape proteasomal system. Further, argued 
that properties of IDPs make them to form low affinity complexes with another protein via 
transient interactions 
22
. 
A few years later, a study suggested that the proteasome cleaves a significant 
proportion of cellular proteins (approximately 20%) independent of the ubiquitination 
process.  Furthermore, studies comparing IDPs with globular proteins in vitro demonstrated 
that only IDPs are susceptible to 20S proteasomal digestion. Based on these observations, it 
was predicted that protein-protein interactions, protein-nucleic acid interactions or any 
functional interaction can protect IDPs from 20S proteasomal degradation. In general, this 
may be achieved either by masking the unstructured domain or by folding it 
149
. 
For clarification, several mechanisms have been proposed by which IDPs are 
prevented from default degradation: (i) IDPs form a functional complex either promoting 
order in or masking IDRs (ii) proteasome gatekeepers, which interact with both the 20S 
proteasome and the potential substrate can protect the latter (iii) nannies- where more specific 
binding to IDRs takes place (iv) the IDPs interact with nucleic acid where the IDPs gains 
more structure upon binding with DNA (v) Competitive binding to ‘decoy’ binding sites in 
DNA ,mainly applicable to transcriptional factors (TFs) (vi) intramolecular interactions 
which block the degradation signal and hence IDRs can survive in a proteases rich 
environment (vii) Local folding by interacting with the partner (viii) Interaction with 
ribosome or ribosome associated proteins 
143
. 
1.8 The concept of fuzzy complexes 
The term fuzzy logic was introduced by Lofti Zadeh with the proposal of fuzzy set 
theory in the year of 1965 
150
. In mathematical terms, fuzzy logic is a many valued logic with 
variables. It is in contrast to traditional binary logic, deviant logic employed to hold partial 
truth value, where truth range between completely true and completely false 
151
. This theory 
can be easily exemplified as the definitions of its usage in the real world: the most used 
machine at one’s home the television: uses sensed variables such as ambient lighting, time of 
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the day and user profile to adjust parameters such as screen brightness, color, contrast and 
sound. 
 In protein biology, the term fuzzy was borrowed by Tompa and Fuxreiter in 2008 in 
order to describe disorder in the bounded states in protein complexes. By definition, fuzzy 
protein complexes are usually composed of intrinsically disordered proteins, which retain 
their conformational heterogeneity in the bound form via transient interactions and required 
for the function. This structural multiplicity or dynamic disorder could contribute to the 
formation, function and regulation of the assembly 
76, 77
. Proteins containing fuzzy regions 
not only preserve their conformational freedom in the bound state, but also impact the 
biological activity of the complexes 
152
. In fuzzy complexes, the multiple conformations that 
IDPs adopt in the bound or complex state cover a continuum, similar to the structural 
spectrum of free, unbound IDPs 
153
, and ranges from static to dynamic, and from full to 
segmental disorder 
77
. Undeniably, the introduction of fuzziness and fuzzy complexes as 
concepts has been tremendously widen the field of IDPs.  
In broader term, two types of structural heterogeneity were considered: polymorphic 
and dynamic. In polymorphic complexes which represent static disorder where in the 
disordered regions have alternative conformations in the complex, whereas in dynamic 
disorder the IDRs exhibit a dynamical continuum of rapidly exchanging conformations 
77, 76
. 
The static and dynamic disorder are considered situational as these properties totally 
depending on the spatial and temporal resolution of employed experiments.   
In the context of mechanism of fuzzy interactions : four different mechanisms were 
defined to understand how distant ID segments in the bound form can affect cellular 
functions and biological activity 
76
 with proteins, RNA or DNA 
154
. 
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Figure 6. Topological classes of fuzzy complexes: A) polymorphic; B) clamp; C) flanking; D) random. 
Solid ribbons (well defined bound stretches), dotted ribbons (non-resolved but functional regions).The 
figure is adopted and modified from 
77
. 
Both specific and non-specific interactions (mostly transient interactions) 
154
 were 
demonstrated to help IDRs to interact with the partner proteins. Some of the interactions were 
reported to increase the local concentration of the binding element leading to productive 
contacts 
17
 and some in contrast lead to auto inhibitory effects when fuzzy regions are 
involved in the binding interface 
155
. All fuzzy interactions mode involves variety of 
mechanisms in relation to conformational heterogeneity of the complex 
156
.  
(i) Conformational selection, 
Selection of a thermodynamically populated conformer suitable for function by shift 
in the conformational equilibrium prior to binding. 
For example interaction of the Max transcription factor with E-box (CACGTG) DNA 
sequences via (bHLH)/(LZ) segment to repress transcription of Myc target genes. The acidic 
N-terminus covers the destabilizing electrostatic potential present at the LZ region. The N- 
and C-terminal regions facilitate the formation of the recognition helices in the bHLH region, 
owing to a strong cooperativity between the bHLH and LZ domains, thus increasing the 
dissociation constant with the E-box by 10 to 100-fold 
157
. 
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(ii) Flexibility modulation,  
Preservation of the conformational heterogeneity of the complex with DNA in order 
to improve the entropy of the binding interfaces.  
The Ets-1 transcription factor is a well reported example which regulates various 
genes; stem cell development and tumorigenesis describing this mechanism. An auto 
inhibitory region in Ets-1-DNA binding regulates unfolding of the HI-1helix. The disordered 
Ser-rich region (SRR) further attenuate its interaction with DNA upon five phosphorylation 
sites within the SRR region and reduces DNA binding affinity by 100-1000 fold 
158
. 
(iii) Competitive binding of the disordered region.  
By competing with the binding partner via electrostatic interactions or steric 
hindrance. 
The acidic fuzzy C-terminal tail of high mobility group protein B1 (HMGB1) 
negatively regulates interaction of the HMG DNA binding domains by occluding the basic 
DNA-binding surfaces 
159
.  
Another example where similar competitive mechanism is observed is the human 
positive cofactor 4 (PC4), when it recruits commonly transcription factors and initiate RNA 
polymerase II (RNAP II). The disordered NTD of PC4 alone lacks considerable affinity for 
either ssDNA or dsDNA. However, the fuzzy region rich in Ser, acidic and Lys of PC4 
interact transiently with the structured CTD and hence compete with ssDNA binding sites 
160
.  
(iv) Tethering 
Improving affinity by increasing the local concentration of the globular, weak affinity 
binding domain. 
The human replication protein A (RPA) is a single stranded DNA binding protein that 
participates in nucleotide excision repair and combinatorial repair. RPA interacts with the 
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DNA through high affinity DNA binding domains (DBDs) which are connected via 78 amino 
acid long ID domain 
161
 and thus results in increase of the local concentration of  DNA 
binding domain near the DNA, hence contribute to improve binding affinity 
162
.  
All mechanisms of fuzzy complexes formation have different binding affinities to 
varying degrees and can be further fine-tuned by post-translational modifications, alternative 
splicing and asymmetric localization in the biological processes and assembly formations 
76
, 
154
. 
The proposal of fuzzy region or regions in the protein complexes has definitely 
widened the scope of IDPs from protein-protein interactions to formation of higher order 
assemblies reviewed historical perspective of fuzziness in protein interactions in reference  
163
. Dynamical ensembles could be shifted upon external signals or changes in the 
intracellular milieu, signifies context dependence. Over the years, it seems fuzziness is highly 
connected to context dependency in the cell however, presently handful of experimental data 
exist in literature. Also, dynamical behavior of higher order assemblies has been reviewed in 
recent study and described how intrinsic fuzziness regulates key feature in higher-order 
assemblies 
87
. Taken together, fuzziness is an intrinsic property in protein-protein 
interactions, supramolecular protein organizations which provides mathematical framework 
for highly heterogeneous and diverse protein interactions. Indeed, fuzzy regions are often 
reported to be involved in protein half-life regulation, gene replication, cell division, immune 
response, signaling or biological activity of the assembly 
152
. In further, our group have 
expanded the repertoire of available fuzzy complexes examples on the basis of experimental 
data: structural and biochemical evidences  
152, 164
. 
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Table 1: Illustration of fuzzy complexes examples involved in various cellular processes 
152
. 
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1.8.1 Nanny model for IDPs  
The nanny model for IDPs is one of the plausible mechanisms to describe the 
turnover of inherently disordered proteins in vivo.  
The main principle mechanism of the model is that when IDPs are in the monomer 
state, they are inherently unstable and tend to degrade by the 20S mediated UI proteasome 
pathway. However, this degradation can be prevented by forming a functional complex upon 
binding to a partner. Formation of a complex is to mask the disordered segment or reshape 
the IDPs structurally. The proteins that bind or mask the IDP and help escape their 
degradation by default termed as nannies 
7
.  
 
 
             Figure 7. The nanny model for intrinsically disordered proteins. The figure is adopted and modified 
from 
7
. 
The nanny model holds three principles: Firstly, a protein should have degradation 
signal attached to the IDR segment. Tumor suppressor p53 is an interesting example to fulfill 
this criterion. The p53 transactivation domain, as well as, regulatory domain is both 
unstructured at the N-terminal and C-terminal end of the protein. However, the N-terminal 
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has sensitivity to degradation by default. Second: a nanny protein should bind to the IDP and 
mask it from degradation. The classical example is again p53 where interactions through N-
terminal are with protein partners block the degradation; however, C-terminal interactions 
fail to do so. Third: The interaction between the IDP and its nanny should be a transient 
association. The newly formed IDPs are at greater risk of proteolysis (20S specifically). Their 
susceptibility to the 20S proteasome and their protection from default degradation provides 
the ground for additional modes of IDP regulation 
7
.  
The important fact is that the nannies are distinct from chaperones as they do not fold 
ID proteins. Their role is to eliminate IDPs destruction unlike chaperones, and further support 
IDPs maturation without affecting their dynamics. Therefore, fuzziness of ID protein-nanny 
interactions is well characterized by experimental data. An interesting and well-studied 
experimentally proven example is IkBα. Free IkBα has unstructured domains at the N- and C-
termini 
50. Monomeric IkBα has been experimentally shown to rapidly degrade via the 
ubiquitin-independent pathway with a half-life of <10mins. Upon binding to NF-kB, IkBα 
escapes degradation by default, hence increases its half-life to many hours. Under this 
condition, IkBα can be destabilized by IκB Kinase (IKK)-mediated phosphorylation followed 
by ubiquitination and degradation 
165, 166
.  
In vitro degradation studies with p21 illustrate that the protein is degraded by the 20S 
proteasome in an ubiquitin independent fashion. However, the degradation could be inhibit 
upon the binding to the proliferating cell nuclear antigen (PCNA) or in the presence of the 
cyclin E and Cdk2 complex 
167, 168
. 
1.8.2 The AP-1 model system 
According to the nanny model, a number of proteins with disordered regions are 
predicted to require specific nannies such as IκBα-NF-κB, Ku70 & Ku80, Cullin-3 complex 
and many more. The nanny-client interaction can be wide spread mechanism present in the 
cell to regulate intrinsically disordered protein turnover 
7
. To test the plausible mechanism of 
nanny function, we hypothesize AP-1 (Activator Protein -1) complex formation is a nanny-
client interaction where c-Jun acts as a nanny for c-Fos.  
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1.9 A historical overview of AP-1  
Historically, AP-1 has been a most extensively studied topic, mostly because of its 
implication in a variety of pathologies, ranging from inflammation to tumorigenesis 
169
.  
For the sake of clarity, I will selectively cover only a few aspects of AP-1 in detail 
relevant to my thesis work. However, overview of AP-1 in several diseases and therapeutic 
intervention in drug development are beautifully covered in several detailed studies  
169–173
.  
AP-1 was first discovered as a TPA-activated transcription factor and found to be 
bound to a cis-regulatory element of the human metallothionein IIa (hMTIIa) promoter and 
SV40 
174
. The very same year, a study identified AP-1 binding site as the 12-O-
tetradecanoylphorbol-13-acetate (TPA) response element (TRE) with the consensus sequence 
5’-TGA G/C TCA-3’ 175. Further studies provided the information that AP-1 DNA binding 
activity is a dimeric transcription factor consisting of various members of the c-Fos, c-Jun 
and other families. c-Jun  was identified as a novel oncoprotein of avian sarcoma virus 
176
, 
and c-Fos was first isolated as the cellular homologue of two viral v-fos oncogenes 
177
. 
However, there is structurally a big difference between the v-Fos and that encoded by its 
cellular counterpart c-Fos. The difference is a 104-base-pair deletion in the carboxyl terminus 
of the v-Fos protein 
178, 179
. Soon after, other family members of Fos and Jun were identified. 
These breakthrough findings ignited new interest to investigate the Fos and Jun gene as well 
as protein structures to gather more knowledge regarding the regulation and function of the 
family members. Eventually, over the years compiling of reviews provided much important 
insight into AP-1 transcriptional dysregulation and oncogenesis. Almost all field of biology 
from modern molecular genetics to structural biochemistry, embark on AP-1 and formulated 
European TMR network to proliferate regulation of AP-1 family members’ function.  
What makes AP-1 so special is its high degree of evolutionary conservation of gene 
structure among different species. Since its discovery, AP-1 has been connected with 
numerous regulatory and physiological functions, and new relationships are still under 
investigation. Not only the similarities but also the differences between species boundaries 
teach us how deeper is the underlying molecular pathways 
180–183
. Furthermore, extended 
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studies in model organisms helped scientists to draw a general agreement that AP-1 is quite 
sensitive complex to its environmental information and accordingly translates it into 
expression of specific gene; found to be true across the species.  
For clarity of thoughts, AP-1 seems quite fascinating as it has been reported to be 
extremely diverse to extracellular stimuli and also for catalyzing the very different biological 
functions of its individual components, however at the same time, it is frustrating to have 
unpredicted results from hypothesis driven research. There are numerous unanswered 
questions for example: how many AP-1 factors are there and do we really need to consider 
context dependency while studying AP-1 and its components diversity? Therefore, it is 
important to study diversity of AP-1 interaction factors together and individual regulation of 
these factors with more specificity.  
1.9.1 Structure of the AP-1 complex; c-Fos and c-Jun 
The best described and studied components of AP-1 are c-Fos and c-Jun. The Fos 
family consists of four proteins (FosB, c-Fos, Fra-2, Fra-1) and on the other hand the Jun 
family includes JunD ,c-Jun, JunB 
184
, reviewed in more detail 
185
. Both the Fos and Jun 
families of eukaryotic transcription factors can homo or heterodimerize to form complexes 
that binds to the 20-nucleotide DNA consensus sequence TGAC/GTCA 
186
. Fos-Jun 
dimerization occurs via the parallel interaction of leucine zipper motifs required for DNA 
binding. The crystallized structure of the bZIP domains of Fos and Jun can recognize the AP-
1 site in both orientations related by a 180 rotational movement by the dyad axis of the 
complex. The structure of Fos and Jun bound to DNA was determined at a resolution of 3.05 
Å 187. 
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Figure 8. (A) The structure of the native bZIP domain of c-Fos/c-Jun bound to AP-1 site (PDB:1fos). 
c-Fos is shown in cyan color and c-Jun shown in blue color. The figure is adopted and modified from 
PDB. (B) The prediction of disorder in c-Fos and c-Jun protein based on IUPred. 
Dimeric c-Fos/c-Jun bZIP domains form an X-shaped α-helical structure 187. c-Jun is 
a 39 kDa protein consisting of an N-terminal transactivation domain (TA), the bZIP domain 
containing a basic DNA binding domain (DBD) followed by an alpha-helical lucine zipper 
dimerization domain (LZD) and a C-terminal region. On the other hand, c-Fos is a 65 kDa 
nuclear phosphoprotein containing several N and C terminal transactivating domains (TA), a 
transrepressing domain (TR) and a central bZIP region. The positively charged amino acids 
residues found within the DNA binding domain of bZIP proteins are required for DNA 
binding activity. The  downstream leucine-zipper domain (LZD) contains a heptad repeat of 
leucine residues which mediates the dimerization of proteins in order to bring two DBDs into 
juxtaposition which in turn facilitates the protein dimer’s interaction with DNA 188. It has 
been found that amino (NH2)- and carboxy (COOH)-terminal regions are quite divergent 
among all AP-1 proteins 
189
.  
As clarification, Landschulz et al. in 1988 was the first scientist to propose a model of 
the structural basis of Fos-Jun interaction involving the so-called ‘leucine zipper’ motif (LZ) 
190
. The importance of the leucine zipper in dimerization that was initially studied on the 
GCN4 transcription factor 
191,192
, eventually received extensive experimental support for 
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other similar classes of protein (reviewed in detail 
185
). During the same time, the leucine 
repeats and the adjacent DBD were also shown to mediate heterodimer formation of c-Fos 
and c-Jun 
193
. c-Fos forms stable heterodimers with c-Jun with higher affinity as compared to 
the Jun-Jun homodimer 
194,195
. In contrast to c-Jun homodimerization, in vitro studies first 
inferred that the c-Fos homodimer is unstable therefore c-Fos can only interact with c-Jun. 
However, more recently the existence of c-Fos homodimerization has also been demonstrated 
in vivo 
196
. 
1.9.2 Regulation of c-Fos protein turnover 
c-Fos is an unstable protein, reported to have shorter half-life of approximately 
60mins while c-Jun has a half-life of 90mins 
197–199
.  
The instability of c-Fos explains its fate from synthesis to degradation. It also 
signifies why its accumulation is transient. c-Fos is a regulator of a diverse set of genes 
important for cell growth and differentiation 
200, 201
. Regarding the expression of the Fos 
gene, it is induced in a variety of mammalian cell types rapidly and transiently within the few 
hours range by growth factors, phorbol esters, neurotransmitters, and membrane-depolarizing 
agents 
202, 203
. The protein can be constitutively expressed in asynchronously growing cells 
204
 
and transiently in other cell types upon various stimuli 
205
. In order to define the regions 
based on the stability, some computational approaches were performed and found out c-Fos 
basically contain three PEST motifs at the C-terminus rich in proline, glutamic acid, serine, 
aspartic acid and threonine. These amino acids were proposed to provide instability to the 
protein, mainly PEST 3 motifs 
206, 207
. Much later, Fos-AD was reported to be unstructured 
and highly mobile protein demonstrated with the help of advance methodologies: a lack of 
(1) H chemical shift dispersion, circular dichroism spectra indicative of unfolded proteins, 
and negative (1)H-(15)N heteronuclear nuclear Overhauser effects. Further, validated with 
the hydrodynamic factors of Fos-AD are found to be an extended structure. Thereby 
collectively results confirmed that the C-terminal domain of human c-Fos is an intrinsically 
disordered 
208
.  
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It was reported that c-Fos degradation is governed by a unique C-terminal which is 
bigger than the PEST3 motif in asynchronous cells; unlike in serum stimulated growing cells 
where N terminal together with C-terminal intrinsically disordered domain and the DBD/LZ 
region responsible for faster degradation of c-Fos. The author conclusively noted that 
multiple structural determinants are deciding factors for rapid c-Fos degradation or 
stabilization which thoroughly depends on the expressed conditions. Further, they indicated 
that both the mechanisms can be functional at the same time within the same c-Fos to 
determine its half-life 
209
. 
 
Figure 9. The different structural determinants responsible for c-Fos degradation in asynchronously 
growing cells and serum stimulated cells. PEST3 is necessary for the degradation of c-Fos compared 
to PEST 2 and PEST1. In exponentially growing cells, PEST3 upstream and full PEST3 length is 
responsible for c-Fos degradation. In cells undergoing the G0/G1 transition, both a C-terminal and 
N-terminal destabilizer are responsible for c-Fos destruction. The figure is adopted and modified 
from 
210
. 
The proteolytic machinery found in cell irrespective of cytoplasmic and nuclear 
localization of proteins 
211
. However, in case of c-Fos, although fractions of cytoplasmic c-
Fos is mediated by 26 ubiquitin dependent proteolytic pathway, majority of nuclear c-Fos is 
subjected to ubiquitin independent degradation (UID) in vivo 
212
. Recently, a study reported 
that in vivo c-Fos undergoes degradation by a default mechanism and regulated by NQO1 
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(20S proteasome gatekeeper) followed by c-Jun for the formation of function AP-1 complex. 
Furthermore, the author speculated that upon interaction, the functional complex adopts much 
lower conformational freedom, and the unstructured domain(s) of c-Fos substrate get masked 
by interacting protein partner c-Jun 
213
. 
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2. AIM OF THE STUDY  
To probe the mechanisms of regulations of ID half-life via protein interactions 
1. Relationship between nanny affinity and ID half-life. 
 The interaction affinity between the nanny and ID client defines the ID client 
degradation by the 20S proteasome.  
 Destabilizing the ID client –nanny interaction strength by affecting the hydrophobic 
contacts reduces the protecting role of the nanny (binding partner) and influence ID 
degradation. 
 Stabilizing the ID client-nanny interaction by introducing a bulkier sidechain at the 
interface slows down the ID protein initial degradation rate and hence provides more 
protection to ID degradation.   
2. What is the nature of the interaction of ID client with nannies? 
 The interaction of ID client is both specific and transient, non-specific interactions 
with nannies which influence half-life of ID client and regulate protein degradation 
via fine-tuning the interaction affinities with a nanny.  
3. How changes in ID regions contribute to changes in half-life? 
 Deletion or truncation of ID region shortens the half-life as it weakens the 
complexation with nanny. 
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3. MATERIAL AND METHODS 
3.1 Materials 
3.1.1. Cell culture media 
Dulbecco's Modified Eagle Medium - high glucose – (Sigma, St Louis, MO, United States) 
Fetal bovine serum (FBS) – (Gibco, Waltham, MA, United States) 
Gultamine – (Gibco, Waltham, MA, United States) 
3.1.2. Antibodies/Reagents 
 GFP antibody (Biolegend, San Diego, California, United States) 
60A8 Anti-Jun antibody (Cell signaling technologies) 
9F6 Anti-Fos antibody (Cell signaling technologies) 
His6- antibody (Sigma) 
Anti-mouse (Advansta, Menlo Park, California, United States) 
Anti-rabbit (Advansta, Menlo Park, California, United States) 
Anti-rat (Advansta, Menlo Park, California, United States) 
MG132 (Sigma, St Louis, MO, United States) 
Protease inhibitor cocktail (Sigma) 
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Luria Bertani (Sigma)  
Page blue staining solution (Thermo scientific) 
Amicon Ultra 50 10000 MWCO ultrafilteration centrifuge tube 
BCA reagent (Thermo scientific) 
Snake memberane 10kDa (Thermo scientific) 
All other materials were purchased from Sigma (St Louis, MO, USA) unless otherwise 
indicated.  
 
 
 
 
 
 
 
 
 
43 
 
3.2 Methods 
 3.2.1 Construction of plasmid based expression vector in different systems 
The constructs pSV-c-Fos-EGFP, pSV-c-Jun-mRFP and pSV-c-Fos-215-EGFP 
(truncated version of c-Fos-EGFP lacking the last 164 amino acids) were kind gifts from 
Joerg Langowski, DKFZ, Heidelberg, containing coding sequence of human full length c-Fos 
and c-Jun. The sequences were PCR amplified and subcloned separately and together in the 
pET-Duet-1 vector between the EcoRI and XhoI sites to obtain expression of a fusion protein 
with an N-terminal His6-tag. The correct composition of these and all following plasmids 
was verified by DNA sequencing and restriction digestion. His6-c-Fos-EGFP and His6-c-
Jun-mRFP were expressed in the Rosetta-2 E.coli cells (Novagen) and Rosetta™ E.coli cells 
(Promega) bacterial strain, which is engineered for optimal eukaryotic codon usage. The PCR 
amplified cDNAs of His6-c-Fos-EGFP and His6-c-Jun-mRFP were also subcloned in the 
pRSFDuet bacterial expression vector, which carries a different antibiotic resistance gene 
(kanamycin) to make simultaneous expression in the same cell from two separate plasmids 
(pET and pRSF) possible. Sequencing has been done using eurofins genomics facilities, 
Ebersberg, Germany.  
We have also generated random mutant library of c-Fos and c-Jun with using 
GeneMorph II Random Mutagenesis Kit (Agilent technologies) and error-prone PCR method.  
3.2.2 Expression and purification of recombinant plasmid fused with EGFP 
and mRFP in Rosetta bacterial system 
Optimal expression condition of His6-c-Fos-EGFP and His6-c-Jun-mRFP were 
chosen by screening different temperatures (18°C, 25°C, 30°C and 37°C), expression times 
(24 hrs, 12 hrs, 6 hrs, 2 hrs) and IPTG concentrations (0.1 mM or 0.5 mM). High level of 
transgene expression was validated by detecting the proteins on 12% SDS-PAGE in bacterial 
lysates, by detecting GFP and RFP fluorescence by flow cytometry in intact bacteria and by 
verifying the GFP and RFP fluorescence spectra with a fluorimeter. Western blotting was 
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used to preclude the presence of prematurely terminated products using anti-His antibody 
(sigma) in (1:5000) dilution.  
The cells were cultured in 300ml LB flask and grown at 37
o
C until OD600 reached 
0.5 followed by the IPTG induction at 16
o
C with 0.5mM IPTG overnight. The cells were then 
collected by centrifugation at 4°C and lysed by sonication in 10 ml of lysis buffer (1% 
TritonX-100 in 1X PBS), 0.1 mM PMSF, protease inhibitor cocktail tablets (Sigma). The 
cells then centrifuged at 20,000 x g for 30 min. Clear supernatant was incubated with 
HisPur
TM
 Ni-NTA metal-affinity resin (Thermo Scientific) for overnight at 4
 o
C. Resins were 
washed several times with buffer A (lysis buffer + 20mM imidazole + 0.1 mM PMSF, 
protease inhibitor cocktail), buffer B (50mM Tris-HCl pH 7.9 + 500mM NaCl + 20 mM 
imidazole + 0.1 mM PMSF, protease inhibitor cocktail), buffer C (50mM Tris-HCl pH 7.9 + 
100mM NaCl + 100 mM imidazole and 500mM Imidazole with 50mM EDTA + 0.1 mM 
PMSF, protease inhibitor cocktail). The purity of the protein and lacked any detectable partial 
product was determined by staining of 12% SDS polyacrylamide gels with Page blue protein 
staining solution (Thermo Scientific). Protein was eluted with buffer D (50mM Tris-HCl pH 
7.9 + 100mM NaCl + 500mM Imidazole + 50mM EDTA + 0.1 mM PMSF, protease inhibitor 
cocktail). Recombinant His6-c-Fos-EGFP, His6-c-Jun-mRFP were dialyzed in “Mini dialysis 
tubes” (nominal molecular weight cutoff at 10kDa, Thermo Scientific) overnight in buffer D 
without imidazole. The purity of the protein was determined by staining of 12% SDS 
polyacrylamide gels with Page blue protein staining solution followed Western blotting using 
anti-His antibody (Sigma) in (1:5000) dilution. The bands were detected by 
chemiluminescence ECL Detection System (Millipore).  
As His6-c-Fos-EGFP was poorly soluble and was present mainly in inclusion bodies. 
Thus, different non-denaturing extraction buffers were also tried. The cells were cultured in 
300ml LB flask and grown at 37
o
C until OD600 reached 0.5 followed by the IPTG induction 
at 37
o
C with 0.5mM IPTG for three hours. The cells were then collected by centrifugation at 
4°C and lysed by sonication in 10 ml of lysis containing 20mM Hepes, pH 7.9, at 4oC. After 
centrifugation of the lysate, the pellet was used to purify insoluble His6-c-Fos-EGFP. The 
pellet was resuspended with 10 ml E-buffer (50 mM Hepes, pH 7.9, 5% (v/v) glycerol, 0.5 
mM of 2-mercaptoethanol, 0.05% (w/v) Na-deoxycholate, and 1% (v/v) NP-40) and 
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homogenized with a Dounce homogenizer and a B-pestle. Extracted inclusion bodies were 
then recovered by centrifugation for 25 min, 14,000 rpm at 4 °C. The His6-c-Fos-EGFP in 
the pellet was solubilized with 10 ml S-buffer (10 mM Hepes, pH 7.9, 6 M guanidine-HCl, 
and 5 mM of 2-mercaptoethanol) on a shaker overnight at room temperature. Denatured 
His6-c-Fos-EGFP protein in S-buffer was adjusted to 15 mM imidazole and bound in batch 
to 1-2 ml HisPur
TM
 Ni-NTA resin on a rotator for 2-4 h at 4°C. The resin was washed 3 times 
with 5 ml each of S-buffer containing 15 mM imidazole, 3 times with 1 ml BC500 containing 
7 M urea and 15 mM imidazole, once with 1 ml BC100 containing 7 M urea and 30 mM 
imidazole, and once with 1 ml BC100 containing 7 M urea and 45 mM imidazole. 
Recombinant His6-c-Fos-EGFP was eluted from the resin with 300mM or 500mM imidazole 
in BC100 containing 7 M urea. Although, very small quantity of protein was recovered from 
the protocol, the 6His-c-Fos-EGFP protein was >80% pure and lack any detectable partial 
product as judged by 12% SDS–PAGE and coomassie blue staining. Purified His6-c-Fos-
EGFP protein in BC100 containing 7M urea and dialyzed in “Mini Dialysis Tubes” (nominal 
molecular weight cutoff at 10 kDa, Thermo scientific) in 7 successive steps of 2 h each 
against BC500 (as above, but with 0.1% NP-40) containing 4M urea (BC500- 4 M urea), 
BC500- 2 M urea, BC500- 1 M urea, BC500- 0.5 M urea, BC500, and twice with BC100. All 
dialysis steps were done at 4°C. After the last dialysis step, the dialyzed proteins were 
centrifuged at 13,000 rpm for 1 hour at 4 °C in an Eppendorf microfuge to remove insoluble 
aggregates. An aliquot (20 µl) was analyzed by 12% SDS–PAGE and coomassie staining and 
stored in small aliquots at -80°C. 
3.2.3 Expression and purification of His6-c-Fos and His6-c-Jun without 
fusion proteins 
Rosetta2(DE3) pLysS E.coli (Novagen) bacterial cultures transformed with the 
constructs containing His6-c-Fos and His6-c-Jun coding sequence were grown to OD600=0.6 
and protein expression was induced with 0.1 mM IPTG for long 3 hours at 37 °C. The cells 
were harvested at 6,000g for 10mins at 4C and sonicated in 6M guanidine-HCl; 25 mM 
Tris-HCl, pH 7.4. Buffers were supplemented with a protease inhibitor cocktail (Sigma). The 
proteins were purified by immobilized metal affinity chromatography on a Ni-Sepharose™ 6 
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Fast Flow resin (GE Healthcare) and washed with 50 volumes of lysis buffer. His6-c-Jun was 
eluted with lysis buffer containing 250 mM imidazole and dialyzed sequentially against 100 
volumes of 4M urea, 2M urea and 1M urea and finally against 25 mM Tris-HCl, pH-7.4; 100 
mM NaCl. For His6-c-Fos variants the buffer was changed to 25 mM Tris-HCl, pH-7.4; 100 
mM NaCl while the proteins were still bound on the resin. They were eluted in the same 
buffer containing 250 mM imidazole and were dialysed against the same buffer without 
imidazole and concentrated with an Amicon-Ultra 50 10000 MWCO ultrafiltration device. 
Protein concentrations were measured by BCA protein assay. 
3.2.4 Designing of c-Fos and c-Jun mutants 
We designed mutants using two methods: Garnier-Osguthorpe-Robson (GOR) 
method and Python-enhanced molecular (PyMOL) graphics tool. The GOR method is 
an information theory-based method for the prediction of secondary structures in proteins. 
PyMOL excels at 3D visualization of proteins, small molecules, density, surfaces, and 
trajectories. We have designed targeted mutants at the c-Fos leucine zipper domain which is 
responsible for dimerization, also at the C-terminal of c-Jun using the GOR4 program and 
PyMoL tool. Single amino acid mutants were generated using the QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technologies). Point mutants were expressed in bacteria 
and purified from pellet as well as supernatant fraction (subsection-3.2.2) followed by 12% 
SDS-PAGE and Western blotting as mentioned above in expression and purification of 
recombinant protein with/without fusion proteins subsections (subsections- 3.2.2 & 3.2.3).  
3.2.5 20S proteasomal degradation assay by ELISA 
c-Fos variants and human 20S proteasome (Boston Biochem) were both diluted in 25 
mM TRIS-HCl, pH7.4; 100 mM NaCl; 0.5 mM DTT to concentrations of 400 nM and 4 nM, 
respectively. The degradation assay was started by mixing 12.5-12.5 μl of the two. 
Degradation of the c-Fos substrates was followed at 37°C and 2 μl samples were collected at 
0, 15, 40 and 80 minutes into 98 μl of PBS, 0.1% Tween-20, 1% BSA containing a protease 
inhibitor cocktail and 1 μM MG132 (Sigma). The c-Fos protein remaining in this solution 
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was bound to 96-well Pierce Nickel-coated plates (Thermo Scientific) for an hour at room 
temperature. The wells were washed three times with PBS-0.1% Tween-20 and they were 
reacted for an hour with 9F6 anti-c-Fos antibody (Cell Signaling Technologies) diluted 1 to 
2000. After washing, the wells were reacted with HRP-conjugated anti-rabbit IgG and 
developed with tetramethyl-benzidine (Sigma). An equal volume of 1 N HCl was added to 
stop the reaction and develop the yellow color, read at 450 nm in a Synergy H1 microplate 
reader (BioTeK Instruments). Protein amounts were determined with a calibration curve 
relating the ELISA signal to protein concentration. The intensity values were first fitted by 
nonlinear fitting to an equation describing single exponential decay with a constant offset and 
the initial degradation rates were calculated as the value of the first derivative of the decay 
curve at time 0 using the software R program. Experiments were repeated three times with 
three independent parallels and the data reported are as mean ± SD from the experiment. 
Statistical significance was determined by unpaired two tailed t-test with Welch’s correction. 
The p ≤ 0.05 value was considered significant. 
3.2.6 Co-Immunoprecipitation assay 
Swollen protein G sepharose beads were taken with a larger excess of IP100 buffer by 
mixing slowly for an hour at room temperature (ca. 20 mg of dry beads will give 100 µl wet 
beads). Master mixture containing 50mg beads + 1 ml of IP100 buffer: 100mM KCl, 25 mM 
Tris-HCl, pH 7.9, 10 % glycerol, 0.1 mM NP40, 0.5 mM DTT. In 100 µl wet beads, 5µg of 
anti-Fos or anti-Jun antibody were added in a 0.5-1 ml of IP100 buffer and mixed by slow 
rotation for an hour at RT. For the antibody to bind for an hour followed by centrifugation at 
1500rpm and rinse three times with excess of IP100. Diluted c-Fos or c-Jun or pre-complexed 
c-Fos/c-Jun into 1 ml of IP100 and add to 20ul antibody/protG beads. Incubate by rotational 
mixing at 4 °C for 2-4 hours. Beads were sediment by using centrifugation at 15000rpm for 
1min followed 3-5 times washing with excess of buffer. For reference control, we used no 
antibodies on the beads and beads coupled with an unrelated antibody. Beads were 
centrifuged for a min to sediment and liquid phase was removed from the tube containing 
sedimented beads. Boiled in Laemmli loading buffer and Western blotting was performed to 
examine the interaction between c-Fos and c-Jun.  
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Dilution of antibodies used: anti-Fos antibody- (1:1000), anti-Jun antibody- (1:1000), 
anti-rabbit secondary antibody (1:10000).   
3.2.7 Binding kinetics analysis 
The binding kinetics of c-Fos variants to c-Jun were measured with a BLItz (PALL-
ForteBio) biolayer interferometer. 1.5 µg of c-Jun was pre-complexed with 60A8 anti-Jun 
antibody (Cell Signaling Technologies) at 37°C for an hour. This resulted in saturation of the 
antibody with Jun. The complex was loaded onto Protein-A Dip and Read biosensors to a 
spectral shift of 3.5 nm. c-Fos variants were diluted into PBS containing 0.1% Tween-20 to 
various concentrations and their association to c-Jun was measured before the biosensor was 
dipped into the same buffer to record the dissociation of the proteins. The binding curves 
were fitted to a 1:1 binding model and ka, kd and KD values were calculated with the BLItz 
Pro™ software. 
3.2.8 Circular dichroism spectroscopy 
Electronic circular dichroism (ECD or CD) far-UV spectra were recorded on a J-810 
spectropolarimeter in 20 mM sodium phosphate, pH 7.4 in a 0.2 mm pathlength quartz cell at 
room temperature. Raw spectra were buffer-subtracted, converted to mean residue 
ellipticities and smoothed. Deconvolutions were made with the Bestsel program. CD 
spectroscopy has been performed by Dr. Sandor Balazs Kiraly and Dr. Tibor Kurtan, 
University of Debrecen. 
3.2.9 Electrophorectic mobility shift assay  
The AP-1 probe was hybridized together from the oligonucleotides 5’-
GTCAGTCAGTGACTCAATCGGTCA-3’and 5’-TGACCGATTGAGTCACTGACTGAC-
3’ by heating their 1:1 molar mixture in water to 95 °C and letting it cool down to room 
temperature. The purified His6-c-Fos and His6-c-Jun proteins were mixed in a 1:1 molar 
ratio in gel shift buffer (25 mM TrisHCl, pH 7.5; 50 mM KCl; 0.5 mM EDTA; 1 mM DTT), 
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incubated for 10 mins at 65 °C and then cooled to room temperature. 1 µl of the diluted oligo 
mixture containing 50 ng of DNA probe was added to 1µg of AP-1 complex in gel shift 
buffer and the binding complexes were allowed to form for 15 minutes at room temperature. 
After adding 2 µl of glycerol the complexes were resolved on an 8 % polyacrylamide gel in 
0.5x TBE buffer at 50 V at room temperature. The bands were visualized by incubating the 
gel in 0.5 µg/ml ethidium bromide.  
3.2.10 Mammalian cell culture and transfection 
To check c-Fos and c-Jun co-expression in eukaryotic, pSV-c-Fos-EGFP and pSV-c-
Jun-mRFP plasmids were used. HEK293AD cells were cultured in DMEM containing 10% 
FBS, 2mM glutamine, and penicillin/streptomycin in a 37 °C incubator in the presence of 5 
% CO2. Transfections were performed in Opti-MEM medium for 5 hours using 
Lipofectamine 2000 in a 2 µl to 1 µg DNA ratio and then the medium was changed back to 
the original culture medium. Images were taken under the fluorescence microscope after 
24hours post-transfection.  
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4. RESULTS: PART-I – DATA USED IN THE STUDY 
4.1 Mutant design  
The structure of the AP-1 complex which is composed of c-Fos and c-Jun is a coiled-
coil 
214
, which is held together tightly by interdigitating hydrophobic contacts (‘leucine 
zipper’). These leucine zipper contacts are complemented by salt bridge at particular 
locations, which gives stability to heterodimer in comparison to homodimer like c-Jun-c-Jun.  
We designed site directed mutants of c-Fos and c-Jun guided by their known crystal 
structure available in the PDB database (PDB: 1fos) using the GOR4 and Pymol softwares. 
We constructed five mutants harboring single point mutation at the interface of leucine zipper 
of c-Fos. Out of five mutants, two mutants (L165V, L172V) affect the hydrophobic network 
and three mutants (E175D, E189D, K190R) perturbing the hydrophilic contacts as shown in 
the Figure 10. Replacements of amino acid from L to V and E to D expected to maintain the 
polarity of the interaction while little deviations in the geometry due to the smaller 
sidechains. On the other hand, K to R substitution mutation provides a bulkier sidechain with 
pi-pi interactions and thus provides additional interactions. We also designed a C-terminal 
truncation c-Fos mutant containing 1-214 amino acid length, with the aim to probe the effect 
of the fuzzy C-terminal tail of c-Fos (215-380AA). 
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Figure 10. Designed mutations (red dots) in the cartwheel representation and the structure of the AP-
1 complex (1fos.pdb ). Mutations in c-Fos (marine, black labels) and the contacting residues in c-Jun 
(cyan, grey labels) are shown by spheres. Fuzzy C-terminal tails are displayed by dashed lines, the 
DNA is colored grey. 
4.2 Expression and purification of recombinant His6-c-Fos and His6-c-Jun  
Purification of c-Fos and c-Jun fused to larger globular protein tags EGFP/mRFP 
proved challenging (subsection 4.7). We expected that these fusion proteins would make the 
largely disordered c-Fos and c-Jun more soluble and stable. However, a single step 
immobilized metal affinity chromatography (IMAC) against the N-terminal 6xHis-tag was 
not sufficient to yield pure protein from the soluble fraction of the bacterial lysate 
homogenized with 1% Triton-X100. Denaturing purification with 6 M GnHCl yielded much 
purer proteins based on SDS-PAGE and Coomassie staining. However, during refolding by 
sequential dialysis these proteins mostly precipitated at the bottom of the tube. The globular 
protein part also never recovered its activity or fluorescence. 
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Figure 11. His6-tagged purified c-Fos and c-Jun proteins used in this study. (A) The purity and 
integrity of the His6-c-Fos variants is shown by Coomassie R-250 staining and western blot after 
SDS-PAGE. (B) The purity and integrity of the His6-c-Jun wildtype is shown by Coomassie R-250 
staining after SDS-PAGE. 
We therefore decided to remove the EGFP/mRFP fusion proteins from the 
recombinant constructs. Instead, these constructs tagged with His6 tag exclusively gave a 
high expression yield and could be purified under denaturing conditions in the presence of 
either 6 M GnHCl, 8 M urea or 1% lauroylsarcosine. In order to purify protein in functional 
form, His6-c-Fos, His6-c-Jun and His6-c-Fos mutants were transformed in Rosetta2 (DE3) 
pLysS E. coli (Novagen) cells by calcium chloride transformation method. The cells were 
grown to OD600=0.6 and protein expression was induced with 0.1 mM IPTG for 3 hours at 
37C. The cells were harvested and sonicated in 6M guanidine-HCl. The proteins were 
purified by immobilized metal affinity chromatography on a Ni
2+
-NTA resin and washed 
extensively using 25 mM Tris-HCl, 100 mM NaCl at pH-7.5. The protein was dialyzed using 
53 
 
250 mM imidazole and concentrated with an Amicon-Ultra 50 10000 MWCO ultrafiltration 
device. Protein concentrations were determined by BCA protein assay. 12% SDS PAGE and 
Western blotting was used to preclude the presence of prematurely terminated products using 
anti-His antibody (1:5000) dilution (Figure 11). His6-c-Fos (refer as c-Fos) and His6-c-Jun 
(refer as c-Jun).  
4.3 Binding kinetic analysis of c-Fos and variants with c-Jun 
With the aim to determine the binding affinity and kinetics of heterodimers of c-Fos 
and c-Jun we took advantage of biolayer interferometry, which allows for kinetic analysis of 
macromolecular interactions using small amounts of material. In a typical experiment, a 
protein A biosensor (the tip of which is coated with protein A) was loaded with anti-Jun 
antibody/c-Jun complex. The 60A8 anti-c-Jun antibody was precomplexed with c-Jun as 
described in Materials and Methods section. The analyte, c-Fos or its mutants, were let bind 
to the c-Jun in known concentrations and the resulting shift in the interference profile was 
recorded as the association phase of the complex. Then, their dissociation into empty buffer 
was also followed in time. From the resulting two-phase sensorgram the association and 
dissociation rate constants (ka and kd) and the equilibrium binding constant (KD) could be 
calculated after fitting the sensograms to either a Langmuir 1:1 or a 2-state conformational 
binding model (see under Material and Methods section). Most interactions could be fitted 
well with a 1:1 model; however, the L165V and L172V mutants better conformed to the 2-
state model apparently reflecting more complex binding kinetics (Figure 12). The KD 
determined for the wild-type complex matched well with literature data determined by other 
methods 
215
. All substituted mutants hampered the stability of the complex when compared to 
the c-Fos complex with the exception of the K190R mutant, which showed a slightly 
increased affinity. The binding affinity was most drastically lowered in the case of the 
truncated c-FosΔ214, which had markedly decreased association and at least two times slower 
dissociation rates. As expected, changes in the hydrophobic interface residues, L165V and 
L172V lowered the affinity of dimerization arguably by perturbing the leucine zipper. 
Reducing the size of the negatively charged residues in E175D and E189D had a moderate 
effect on dimer formation. The mutant c-FosK190R showed tighter binding between c-Fos 
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and c-Jun compared to the c-Fos/c-Jun complex. As noted, interface mutations have larger 
impact on the association of the dimer compared to dissociation kinetics (Table 2). 
 
Figure 12. (A) Binding kinetics of c-Fos mutants to c-Jun. c-Jun was immobilized by attachment 
through an anti-c-Jun antibody to a protein A covered surface. Binding of free wild-type c-Fos, point 
mutants predicted to decrease, or increase the affinity of the complex, and of a C-terminal deletion 
mutant at the indicated concentrations to immobilized c-Jun were determined by biolayer 
interferometry. 
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 ka (x10
3 M-1s-1) kd (x10
4 s-1) KD (nM) affinity 
ratio to 
wild type 
c-Fos 80.3 ± 18.5 32.4 ± 1.95 40.4 ± 22.6 – 
c-FosL165V 1.82 ± 0.0337 23.8 ± 0.897 1310 ± 73.8 0.03 
c-FosL172V 8.16
 ± 0.197 55.1 ± 2.28 676 ± 79.7 0.06 
c-FosE175D 7.76 ± 0.119 11.6 ± 0.738 149 ± 85.3 0.27 
c-FosE189D 5.53 ± 0.0637 7.02 ± 0.474 127
 ± 125 0.32 
c-FosK190R 76.4 ± 0.876 7.75 ± 0.481 10.1 ± 5.79 4.0 
c-Fos214 3.11 ± 0.421 77.8 ± 1.44 2500
 ± 511 0.02 
Table 2. Experimental binding affinities and computed interaction energies of c-Fos mutants with c-
Jun. Association and dissociation curves were determined at 37C by BLItz analysis using a 1:1 
binding model. c-Fos mutants were added to Jun labelled biosensors in different concentrations. Jun 
was marked by 60A8 Jun antibody (Cell Signaling Technologies). The equilibrium dissociation 
constant was determined as KD=kd/ka, where kd is the dissociation, ka is the association rate.  
4.4 Determination the degradation rates of c-Fos alone and in the complex 
with c-Jun 
Proteins bearing intrinsically unstructured regions (IUPs) are prone to degradation in 
vitro by the 20S proteasome 
10
. Also, in vivo, these proteins can undergo degradation in an 
ubiquitin-independent fashion by a “degradation-by-default” mechanism 216. The C-terminal 
half of c-Fos is intrinsically unstructured 
212
 and involved in UID of c-Fos 
213
. To examine the 
behavior of c-Fos as an IUP, we incubated c-Fos with purified 20S proteasomes and revealed 
that c-Fos was efficiently degraded alone. Next, we determined the sensitivity of c-Fos for 
20S proteasomal degradation in vitro in the presence or absence of its binding partner, c-Jun. 
In the assay the amount of the remaining c-Fos was followed by ELISA over time. We fitted 
the decay curves of c-Fos alone or in the presence of c-Jun to a one phase decay model and 
determined the initial degradation rate (V0) and the degradation half-life (t1/2) (Figure 13 and 
Tables 3 and 4).  
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Figure 13. Degradation of various c-Fos mutants and their complexes formed with c-Jun by the 20S 
proteasome in vitro. (A) The residual amounts of wild-type c-Fos or its mutants were determined by 
anti-c-Fos ELISA after 0, 15, 40 and 80 minutes of incubation in the presence of purified 20S 
proteasome. The kinetics of the decay was also determined in the presence of equimolar c-Jun. 
Unpaired two tailed t-test. 
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 Initial degradation rate (O.D./min) 
free (x 10-2) + c-Jun (x 10-2) ratio 
c-Fos 3.00 ± 0.0014 0.74 ± 0.0060 0.247 
c-FosL165V 3.46 ± 0.0004 1.01 ± 0.0022 0.292 
c-FosL172V 3.31 ± 0.0077 1.98 ± 0.0046 0.598 
c-FosE175D 3.08 ± 0.0018 1.29 ± 0.0030 0.419 
c-FosE189D 3.07 ± 0.0009 1.46 ± 0.0066 0.476 
c-FosK190R 2.46 ± 0.0072 0.24 ± 0.0008 0.097 
c-Fos214 2.86 ± 0.0048 2.69 ± 0.0048 0.941 
Table 3. Initial degradation rates of c-Fos and its mutants with and without c-Jun during degradation 
by purified human 20S proteasomes. Degradation assays were performed using purified human 20S 
proteasome by measuring c-Fos concentration after 0, 15, 40 and 80 minutes. Nonlinear data fitting 
was carried out by the R program. All reactions were run in triplicates. 
 
 Half-life (min) 
 free + c-Jun 
c-Fos 11.64 ± 0.44 19.18 ± 9.00 
c-FosL165V 10.84 ± 0.13 14.16 ± 3.74 
c-FosL172V 10.93 ± 3.53 15.69 ± 2.76 
c-FosE175D 23.95 ± 2.35 23.67 ± 7.90 
c-FosE189D 17.36 ± 1.15 20.73 ± 2.32 
c-FosK190R   9.28 ± 2.86 151.95 ± 33.87 
c-Fos214   9.07 ± 1.25 13.85 ± 4.09 
Table 4. Half-lifes of c-Fos and its mutants with and without c-Jun during degradation by purified 
human 20S proteasomes. Degradation assays were performed by measuring c-Fos concentration after 
0, 15, 40 and 80 minutes. Nonlinear data fitting carried out by the R program. All reactions were run 
in triplicates. 
E to D replacements stabilized the free c-Fos, whereas the K190R and c-FosΔ214 did 
not affect or very slightly shortened the half-life. As shown in Table 4 the interaction of c-Jun 
significantly slowed the degradation of c-Fos, increasing its half-life from 11.64 minutes to 
19.18 minutes, which is a par excellence demonstration that it is the ‘nanny’ of its partner.  
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Since we found that a fraction of substrate escaped degradation at the end of the 
proteasomal degradation assay we also determined the initial degradation rates in order to 
characterize how the affinities manipulated by the site-specific mutations or C-terminal 
truncation influenced the ability of the nanny c-Jun to protect the c-Fos mutants from 20S 
proteasomal degradation.  
We could show that the change in the initial degradation rate upon addition of c-Jun 
(v0,+c-Jun/v0,free) correlated positively with the KD, that is, mutations decreasing the affinity 
between the two proteins to a larger degree prevented c-Jun from protecting its client more 
(Figure 14). We observed that all the designed mutations had a larger impact on the c-Fos 
degradation rate in the presence than in the absence of c-Jun, whereas the v0 in the free forms 
were very comparable between mutants (Table 3). The c-Fos turnover is increased in all 
mutants, irrespective of the destabilizing or stabilizing behavior of the mutations. The impact 
on the initial degradation rates of c-Fos, however, is in accord with the interaction affinities 
observed by the BLItz measurements. As expected, destabilizing mutations affecting 
hydrophobic contacts (L165V, L172V) exhibited smaller decrease in the initial degradation 
rates (ΔVmut/ΔVwt) compared to those affecting hydrophilic interactions (E175D, E189D). 
Only mutant K190R slowed down the initial degradation rate as compared to wildtype c-Fos 
(Figure 13).  
We included the C-terminal deletion mutant in the analysis together with the point 
mutants, because the deletion did not alter much the degradation rate of the mutant compared 
to the wild-type in the absence of c-Jun. The comparison of c-Fos and c-FosΔ214 revealed that 
the presence of the c-Fos tail within the complex also decreased the degradation rate almost 
by almost 4-fold (Table 3). Thus, removal of the fuzzy C-terminal segment considerably 
decreased c-Fos protection and complexation with c-Jun could barely influence the 
degradation rate (Table 4). 
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Figure 14. Change in c-Fos degradation rate via c-Jun interactions (v0, +c-Jun/v0, free) as a function of 
the binding affinity. The experimental KD values are shown on a logarithmic scale. 
4.5 Estimation of protein disorder in free c-Fos and c-Fos/c-Jun complex by 
CD-spectroscopy 
To determine whether protein disorder is preserved when c-Fos and c-Jun interact 
with each other or one or both of the proteins fold up upon binding to its partner, we 
performed near-UV circular dichroism spectroscopy. We were also interested to assess the 
impact of the mutations on the structure of c-Fos in free form and in complex with c-Jun. Our 
observations are similar with the previous experimental results, almost half of the full length 
c-Fos (185 residues) does not possess regular secondary structures and remains extended 
form 
208
. Our results show that the CD-spectrum of the complex is very similar to the average 
of the spectra of the individual proteins with slightly increased in helical population (Table 
5). Secondary structure prediction estimated the disorder content to be around 60 % in all 
three cases (60.4 % for c-Fos, 61.3 % for c-Jun, 58.9 % for the complex), our results 
indicating that c-Fos and c-Jun retain as much disorder in the heterodimeric form as in their 
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monomeric forms, suggesting that fuzzy interactions between the disordered tails are 
responsible for the nanny effect.  
 
 
 
Figure 15. A) Near-UV ECD-spectra of c-Fos, c-Jun monomeric proteins and the c-Fos/c-Jun 
complex.  
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-Helix 
strand 
(antiparallel) 
strand 
(parallel) 
Turn Other 
c-Fos 11.0 20.2 7.4 12.6 48.7 
c-Jun 17.5 17.9 6.2 14.1 44.4 
c-Fos/c-Jun 14.2 19.2 7.8 14.7 44.2 
c-FosL172V 17.1 21.1 2.4 14.9 44.5 
c-FosL172V/c-Jun 12.2 31.1 0.0 14.3 42.5 
c-FosE175D 23.9 19.1 3.4 11.6 42.1 
c-FosE175D/c-Jun 23.9 19.1 3.4 11.6 42.1 
c-Fos214 19.2 18.5 1.1 15.0 46.2 
c-Fos214/c-Jun 14.9 17.9 5.5 14.6 47.1 
Table 5. Propensity of secondary strutcure elements (%) as determined by ECD spectroscopy.  ECD 
spectra were recorded on a J-810 spectropolarimeter in 20 mM sodium phosphate, pH 7.4 buffer 
solution with a 0.2 mm quartz cell at room temperature.  Raw spectra were corrected with the blank, 
then were converted to mean residue ellipticities and were smoothed. Deconvolution was performed 
by the BeStSel program. 
Thus, we can highlight that c-Fos forms a fuzzy complex with c-Jun, where 45.8% of 
the residues remain to be disordered which is consistent with previous FRET and FCCS 
results 
215
. 
On the other hand, L172V and E175D replacement cause only a minor increase in the 
secondary structure of c-Fos. As observed, structural disorder of the mutants is retained upon 
assembly with c-Jun, with minor impact on the secondary structure properties of the L172V 
and E175D mutant assemblies as compared to the wild-type protein. Although surprisingly, 
the removal of disordered C-terminal region from full-length c-Fos protein did not modify 
considerable ordering when compared with c-Fos, in the absence of c-Jun.  
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4. RESULTS: PART-II-UNPUBLISHED DATA 
4.6 Generation of random mutant library  
To design random mutant libraries of c-Fos and c-Jun, we made use of error-prone 
PCR method using a GeneMorph II Random Mutagenesis Kit. Error-prone PCR method is a 
polymerase chain reaction and was performed using Mutazyme (2.5 U/µl) enzyme to 
generate random mutations in the c-Fos and c-Jun wildtype sequences. PCR products of c-
Fos and c-Jun were restriction digested followed their ligation with the plasmid vector 
containing EGFP and mRFP fusion proteins respectively. The ligated plasmids were 
transformed into DH5α competent cells in order to have isolated mutant colonies on the agar 
plate. To account the rate of mutations, sequencing was performed using forward and reverse 
sequencing primers. Simultaneously, to determine the size of each library, colonies were 
counted manually. In total, two random libraries with higher and lower mutation rates have 
been generated from full length cFos and cJun DNA sequence and will be used for future 
experiments (Table 6).  
 
Library Name Mutation Rate/Gene 
c-Jun library A 4-9 
c-Jun library B 1-4 
c-Fos library A 1-5 
LIBRARY SIZE – 105 
Table 6: Random mutant library of c-Fos and c-Jun DNA sequence using Gene Morph-II Random 
Mutagenesis. 
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4.7 Expression and purification of His6-c-Fos-EGFP and His6-c-Jun-
mRFP. 
The in vitro expression plasmid pETDuet-1 containing the His6-c-Fos or His6-c-Jun 
cDNA coding region was expressed in E.coli BL21 (DE3) competent cells. Cells were lysed 
by sonication and the insoluble fraction was dissolved in a guanidine-HCl-containing buffer 
and homogenized with a Dounce homogenizer and a B-pestle. Extracted inclusion bodies 
were then recovered overnight at room temperature. Denatured His6-cFos-EGFP protein 
bound in batch to 1-2 ml HisPur
TM
 Ni-NTA resin on a rotator for 2–4 hours at 4 °C. 
Following the elution, fractions purity was determined by 12% SDS-PAGE as shown below 
in the figure 16. Pure (>80 %) fractions were then pooled, and dialyzed. Western blotting was 
also used to verify the presence His6-c-Fos-EGFP and His6-c-Jun-mRFP proteins using anti-
His antibody (1:5000) dilution in the eluted fractions. The expression and purification 
protocols were identical for both the wild-type and the mutants. 
 
Figure 16. (A) Separation of purified His6-c-Fos-EGFP WT and mutant protein on SDS-PAGE gel. 
Lane1- WT, Lane2- His6-c-FosΔ214, Lane3- His6-c-Fos166-EGFP, Lane4- His6-c-Fos168-EGFP, 
Lane5- His6-c-Fos175-EGFP, Lane6- His6-c-Fos176-EGFP, Lane7- His6-c-Fos182-EGFP, Lane8- 
His6-c-Fos189-EGFP, Lane 9- His6-c-Fos190-EGFP. (B) Western Blot analysis after SDS-PAGE of 
purified His6-c-Fos-EGFP WT, His6-c-Jun and mutant proteins. Lane1- His6-c-Jun WT, Lane2- 
His6-c-Fos190-EGFP, Lane3- His6-c-Fos189-EGFP, Lane4- His6-c-Fos182, Lane5- His6-c-Fos176-
EGFP, Lane6- His6-c-Fos175-EGFP, Lane7- His6-c-Fos168-EGFP, Lane8- His6-c-Fos166-EGFP, 
Lane9- His6-c-FosΔ214-EGFP, Lane10- His6-c-Fos-EGFP WT. 
64 
 
4.8 Expression and purification of recombinant His6-c-Jun and its mutants. 
Purification c-Jun fused to larger globular protein tag mRFP proved challenging. We 
expected that these fusion proteins would make the largely disordered c-Jun more soluble and 
stable. However, a single step immobilized metal affinity chromatography (IMAC) against 
the N-terminal 6xHis-tag was not sufficient to yield pure protein from the soluble fraction of 
the bacterial lysate homogenized with 1% Triton-X100 (Figure 17). Denaturing purification 
with 6 M GnHCl yielded much purer proteins based on 12% SDS-PAGE and Coomassie 
staining. However, during refolding by sequential dialysis these proteins mostly precipitated 
at the bottom of the tube. The globular protein part also never recovered its activity or 
fluorescence. 
 
Figure 17. His6-tagged purification of c-Jun wildtype and mutants protein. The purity and integrity of 
the c-Jun variants is shown by Coomassie R-250 staining after SDS-PAGE. 
We therefore decided to remove the mRFP fusion proteins from the recombinant 
constructs. Instead, these constructs tagged with His6 tag exclusively gave a high expression 
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yield and could be purified under denaturing conditions in the presence of either 6 M GnHCl, 
8 M urea or 1% lauroylsarcosine. In order to purify protein in functional form His6-c-Jun and 
His6-c-Jun mutants were transformed in Rosetta2 (DE3) pLysS E. coli (Novagen) cells by 
calcium chloride transformation method. The cells were grown to OD600=0.6 and protein 
expression was induced with 0.1 mM IPTG for 3 hours at 37C. The cells were harvested and 
sonicated in 6M guanidine-HCl. The proteins were purified by immobilized metal affinity 
chromatography on a Ni
2+
-NTA resin and washed extensively using 25 mM Tris-HCl, 100 
mM NaCl at pH-7.5. The protein was dialyzed using 250 mM imidazole and concentrated 
with an Amicon-Ultra 50 10000 MWCO ultrafiltration device. Protein concentrations were 
determined by BCA protein assay. 12% SDS PAGE and Western blotting was used to 
preclude the presence of prematurely terminated products using anti-His antibody (1:5000) 
dilution. We plan to use c-Jun mutants in future.  
4.9 Verification of the interaction of the purified c-Fos and c-Jun proteins  
We next investigated the physical interaction between the purified c-Fos and c-Jun 
proteins in vitro. To verify the interaction between His6-c-Fos (refer as c-Fos) and His6-c-
Jun (refer as c-Jun) we co-immunoprecipitated them using 60A8 anti-c-Jun antibody. 
Controls included c-Fos added to protein A sepharose beads, c-Fos added to protein A 
sepharose beads carrying the antibody in the absence of c-Jun, and c-Fos added to protein A 
sepharose beads carrying an isotype matched unrelated rabbit mAb. As shown in Figure 18B, 
c-Fos co-immunoprecipitated with c-Jun.  
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Figure 18. Interaction between c-Fos and c-Jun using in vitro technique. (A) Schematic 
representation of a standard co-immunoprecipitation protocol (B) lane 1; c-Jun alone, lane 2; c-Fos 
alone, lane 3; c-Fos bound to empty beads, lane 4; c- Fos bound to anti-Jun + c-Jun, lane 5; c- Fos 
bound to anti-Jun, lane 6; c-Fos bound to unrelated IgG. 
c-Fos binding to c-Jun was specific, because it could not be detected in the absence of 
c-Jun. Importantly, binding of the anti-c-Jun antibody to c-Jun did not interfere with the c-
Jun/c-Fos interaction, which will be crucial for the immobilization of c-Jun for binding 
kinetic measurements by biolayer interferometry.  
4.10 Binding of purified c-Fos and c-Jun to the AP-1 element 
To verify that the His6-tagged c-Fos and c-Jun form a functional heterodimer that is 
able to bind the consensus AP-1 response element a probe containing the TRE sequence 
TGACTCA was hybridized from two oligonucleotides and used for an electrophoretic 
mobility shift assay by incubation with the purified c-Fos and c-Jun. When both c-Fos and c-
Jun were mixed with the oligonucleotide a shift could be detected in the mobility of the probe 
during acrylamide gel electrophoresis indicating that the c-Jun and c-Fos proteins were able 
to heterodimerize and the complex bound the cognate AP-1 response element in the DNA. In 
contrast, c-Jun alone failed to bind to the DNA (Figure 19).  
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Figure 19. Electrophoretic mobility shift assay for His6-c-Fos and His6-c-Jun heterodimer binding to 
an AP-1 site containing fragment. Lane1; control (probeDNA), Lane2; c-Fos/c-Jun with probe DNA 
and Lane3; c-Jun/c-Jun with probe DNA. 
4.11 Co-expression of c-Fos-EGFP and c-Jun-mRFP in mammalian system  
In eukaryotic HEK293AD cells, co-expression of mRFP-tagged c-Jun with c-Fos-
EGFP tremendously increased their expression (Figure 20). As the expression of both 
proteins was driven by strong CMV promoters, which would not be influenced by the 
overexpression of the factors themselves, the proteins post-translationally stabilized each 
other. 
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Figure 20. Co-expression of c-Jun increases the steady-state expression level of c-Fos-EGFP. c-Fos-
EGFP was expressed either alone or together with c-Jun-mRFP in HEK293AD cells. Increasing 
amounts of co-expressed c-Jun-mRFP increased the level of the c-Fos-EGFP.  
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5. DISCUSSION 
IDPs play indispensable functions in the life of the cell being involved in essentially 
every cellular process, from transcription regulation through DNA repair to signal 
transduction. Consequently, precise control of the ever required levels of IDPs is crucial for 
maintaining all cellular processes 
139
. Besides being controlled at synthesis the termination of 
a protein’s life-span also offers a point for regulation. The half-lives of proteins range from 
minutes to days and change in response to the biological context, attesting to the exquisite 
fine-tuning of protein turnover. Alterations of half-life affect the immune and stress 
responses, DNA repair, programmed cell death, and flaws of protein homeostasis have been 
linked to developmental problems, cancer and neurodegenerative disease 
217–219
. For instance, 
a merely 8-minute increase in the half-life of the Hes7 transcription factor severely disrupts 
embryonic development in the mouse 
220
. The proteasome is the major machinery that is 
responsible for the elimination of damaged, misfunctional or misfolded sequences and also 
for specific and controlled degradation of proteins in eukaryotic cells 
145
. The eukaryotic 
proteasome consists of a 19S subcomplex for the recognition and active unfolding of 
ubiquitinated proteins, and a 20S core complex harboring the catalytic protease subunits. The 
assessment of protein half-life on a genomic scale in several organisms yielded results, that 
correlate surprisingly well with dynamic features of the protein sequences, suggesting that the 
decision to degrade a protein is strongly connected to the unstructured/unfolded state. The 
20S particle is not necessarily complemented with the recognition particle and also exists and 
functions independently. Natively unstructured proteins can bypass the need for the 19S 
particle explaining that proteins which lack a tertiary structure in their native states are 
enriched among substrates of the 20S proteasome. This leads to the identification of specific 
biochemical mechanisms by which the amino acid sequence can determine the rate of a 
protein’s degradation. The observations are consistent with a view in which dynamic 
polypeptide segments of lengths (>30 AA) sufficient to enter the proteasome’s cavity (either 
at the termini of a protein or internally) are needed for efficient degradation and proteins 
containing such segments have shorter half-lives. 
221
. The sequence composition of these 
unstructured initiation sites further modulates the affinity for the proteasome and determines 
the proteasome’s processivity along a protein 132. The other paramount element in deciding 
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the half-life of proteins is interaction with regulatory proteins. To distinguish non-functional 
segments and natively unstructured yet very functional sequences presents a challenge to 
regulated protein degradation 
222
. The survival of disordered proteins, how they evade 
degradation by default by the 20S proteasome even in an ubiquitination independent manner 
needs to be accounted for. A plausible model that provides explanation for this proposes that 
protein interactions might shield exposed dynamic regions and make them inaccessible for 
the 20S core particle. This mechanism, which seems to have a wide-spread effect on 
intracellular levels of important disordered proteins, has been termed the ‘nanny hypothesis’, 
where the protective partner factor is referred to as ‘nanny’ 10, 7.  Although the nanny model 
has been applied to a number of examples, where complexation extends protein half-life (for 
example ikBa-NFkB 
166
, Ku70-Ku80 
223
  the detailed molecular mechanisms remained to be 
elucidated. 
In the present study we used the activator protein 1 (AP-1) as a model system to study 
the relationship between ID protein interactions and half-life. We aimed to explore how 
specificity and affinity of protein interactions between an IDP and a partner influences 
default 20S proteasomal degradation, that is, how c-Fos turnover is modulated by specific 
mutations affecting specific interactions by the structured elements at the contact sites with c-
Jun and by the presence of the fuzzy tail.  
We opted to use the full-length c-Fos (380 AA) and c-Jun (331 AA) and considerable 
effort had to be invested in the purification of the proteins. A single step IMAC against the 
N-terminal 6xHis-tag was not sufficient to yield pure protein from the bacterial lysates 
homogenized with Triton-X100 and a further reverse phase chromatography step also proved 
insufficient. Purification of c-Fos and c-Jun fused to larger globular protein tags, such as 
EGFP/mRFP proved challenging. We expected that these fusion proteins would make the 
largely disordered c-Fos and c-Jun more soluble and stable, surprisingly was insoluble in a 
broad spectrum of buffers. Denaturing purification with 6 M GnHCl yielded soluble and 
much purer proteins based on 12% SDS-PAGE and Coomassie staining, but during refolding 
by sequential dialysis these mostly fell out of solution and precipitated. The globular protein 
part also never recovered its activity. We finally removed the EGFP and mRFP fusion 
proteins, and constructs tagged with His6 exclusively gave a high expression yield and could 
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be purified under denaturing conditions in the presence of either 6 M GnHCl and could be 
successfully refolded.  
We designed five mutants to affect either the hydrophilic interactions or the 
hydrophobic contact points within the leucine zipper. In the mutants E175D, E189D and 
L165V and L172V shorter side-chains were introduced in place of two glutamic acid residues 
or two leucines of the LZ to perturb the ideal geometry and to plausibly reduce binding 
affinity. The lysine to arginine (K190R) replacement introduces a longer charged side chain 
with additional π interactions. The C-terminus of c-Fos has been shown to behave 
dynamically both when free and as bound to c-Jun. We designed a truncation mutant lacking 
the C-terminus (c-FosΔ214) to investigate the effect of this C-terminal fuzzy tail and its 
interplay with the structured interacting regions.  
The alteration of proteasomal removal can theoretically be the consequence of 
enhanced folding upon binding of two proteins to each other. To determine whether protein 
disorder is preserved when c-Fos and c-Jun interact with each other or one or both proteins 
fold up upon binding to their partners, we performed electronic circular dichroism (ECD) 
spectroscopy in the free and the bound states of c-Fos, a hydrophilic (E175D) and a leucine 
mutant (L172V), and the C-terminally truncated c-FosΔ214. The CD-spectrum of the c-Fos/c-
Jun complex was very similar to the average of the spectra of the individual free proteins, and 
we noted that complex formation with c-Jun only slightly increased the helical population as 
compared to the c-Fos free state, meaning that extensive ordering did not occur. Consistent 
with previous FRET and FCCS results, we could confirm that c-Fos formed a fuzzy complex 
with c-Jun, where 45.8% of the residues remain disordered 
215
. The mutants L172V and 
E175D showed only minor increases in their secondary structures with respect to c-Fos. The 
secondary structure content prediction estimated that the structural disorder of the c-
FosL172V and c-FosL175D mutants is retained upon assembly with c-Jun, with small impact 
on the secondary structure properties as compared to the wild-type protein. On the other 
hand, we did not observe any substantial unfolding of the structured part in c-FosΔ214, as the 
number of residues with regular secondary conformations (> 200 AA in full-length c-Fos, 
113 AA in c-FosΔ214) exceeded the size of the bZIP (62 AA). Taken together, our data 
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demonstrated consistently with previous observations by others that c-Fos and all the studied 
variants form fuzzy complexes with c-Jun and do not completely fold upon binding.  
The biolayer interferometric binding kinetics measurements revealed that the binding 
affinities between c-Fos substitution mutants and c-Jun decreased by less than two orders of 
magnitude, except the one mutant K190R mutation when compared to full length c-Fos. We 
observed that inclusion of the fuzzy tail in full-length c-Fos improved binding affinity (40 
nM) in contrast to interaction studies determined between the leucine zippers (63 aa, KD=54 
nM) 
224
. Perturbing the hydrophobic interface (L165V, L172V) had the most considerable 
effect on the stability of the complex due arguably to looser zipper contacts. Reducing the 
size of the negatively charged residues (E175D, E189D) had a moderate impact on KD, due to 
weaker electrostatic stabilizing interactions. The K190R mutation slightly stabilized the 
heterodimer via additional π-π interactions with Q313. The C-terminal truncation in c-FosΔ214 
considerably destabilized dimer formation. The removal of the fuzzy C-terminal region in c-
FosΔ214 considerably increased the dissociation rate from c-Jun as compared to the wild-type 
protein. The association of the bZIP domains is limited by electrostatic repulsion, which is 
usually masked by the flanking disordered regions. A similar trend was observed in c-Max 
and c-Myc assembly 
157, 225
. Along these lines, truncating the fuzzy tail in c-FosΔ214 
unfavorably affects formation of the coiled-coiled structure. We believe that the effect of the 
C-terminal fuzzy tail of c-Fos can also be interpreted within the framework of the fly-casting 
model. Disordered regions establishing nonspecific (e.g. electrostatic) interactions can 
increase the effective local concentration of a neighboring specific structured interacting 
region as this tethered segment is only free to sample a limited space  
226, 227
. Along these 
lines fuzzy regions in protein complexes can serve as nonspecific anchors, which remain 
attached and decrease dissociation rates even in the absence of specific contacts 
228
 In accord 
with previous data, the association kinetics seems to be affected by mutations in full-length c-
Fos 
229, 230
. However, binding kinetics of full-length proteins without complete folding might 
exhibit complex kinetics 
164, 231
 (and references therein), as compared to truncated protein 
fragments, which fold upon binding 
232
.  
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Replacements of charged residues in c-Fos also slowed down the dissociation kinetics 
by 3-4 folds. We noted in case of the c-FosL165V and c-FosL172V mutants using a 2 state 
mode indicate more complex kinetics. 
We evaluated how c-Fos turnover is modulated by the mutations at the specific 
contact sites with c-Jun and by the presence of the unstructured tail. We set up an ELISA 
based proteasomal degradation assay to quantitate in vitro the sensitivity of the different c-
Fos mutants to 20S proteasomal degradation in the presence or absence of c-Jun. We used the 
change in the initial degradation rate (V0) and the extension in the half-life (t1/2) to 
characterize the stabilizing effect. An equimolar c-Jun slowed the rate of degradation of c-
Fos ~5 times and increased its half-life from 11.64 minutes to 19.18 minutes, which was a par 
excellence demonstration that c-Jun is the ‘nanny’ of its partner, c-Fos. All the incorporated 
substitutions had a larger effect on c-Fos half-life in the presence rather than in the absence of 
c-Jun, and the V0 values corresponding to the monomeric states did not change much in the 
site-directed mutants. This can be expected if the mutations do not influence the interaction 
with the proteasome per se, and if the degradation signal is conserved in the disordered tail. 
c-Fos turnover was prolonged in all cases irrespective of whether a mutation stabilized or 
destabilized the complex indicating that interactions with the binding partner - however weak 
or strong - influenced c-Fos degradation.  We noted that the impact on the initial degradation 
rates correlated inversely with the interaction affinity of the mutant. The destabilizing L172V 
mutation, which affects hydrophobic contacts exhibited smaller decrease in the initial 
degradation rates than those affecting hydrophilic interactions (E175D, E189D). 
Destabilizing the complex reduced the protecting role of the binding partner as compared to 
the wild-type. On the other hand, the stabilizing K190R mutation slowed down the initial 
degradation as compared to the wild-type c-Fos. The c-FosL165V somewhat deviated from 
the trend most probably due to its considerably decreased helicity and decreased dissociation 
rates. The presence of the c-Fos fuzzy tail in the complex also decreased the degradation rate 
almost by 4-fold, consistent with its observed contribution to the stability of the AP-1. Thus, 
removal of the fuzzy C-terminal segment decreases c-Fos protection via weakening the 
complexation with c-Jun. Taken together, although interaction affinity is likely to be the 
major determinant in stabilizing c-Fos, the relationship appears to be rather complex. Overall, 
we showed that protection by c-Jun qualitatively correlates to the binding affinity; and 
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destabilizing the complex reduces the impact of the mutation on degradation rates. However, 
there are indeed additional factors, which can also influence stabilization, for example 
decreased dissociation rates or steric effects (most prominent may be in the larger system) 
indicating a rather complex protection mechanism. Taken together our results demonstrate 
that both specific and transient, nonspecific interactions influence half-life.  
That c-Fos and c-Fos mutants retained as much disorder in the AP-1 complex as in 
their monomeric forms, suggests that fuzzy interactions between the disordered tails had to 
be responsible for the nanny effect. This is consistent with the fact that removal of the C-
terminal of c-Fos dramatically increased the KD of the interaction implying that the removed 
segment contributed substantially to binding. Also, when c-Fos is truncated in its C-terminal 
segment c-Jun was unable to exert nearly as significant a protection from the 20S 
proteasome. Our findings imply that protection of disordered regions can be achieved without 
inducing a proper stable structure and many binding configurations could be visited in the 
complex without disturbing the conformational entropy. The protective role of fuzzy 
interactions from the 20S proteasome could also provide a plausible explanation for how low-
complexity sequence motifs might serve as selective inhibitors of proteolysis 
233, 234
 . Tandem 
repeats of short, linear sequences are frequently associated with proteins, which form higher-
order protein structures or undergo liquid-liquid phase transition 
235
. Interactions between 
these motifs are often not specific or well-defined, and multivalency 
236
 or fuzziness 
237
 is a 
ubiquitous feature of these associations. We may assume that such weak, heterogeneous 
contacts could also serve to protect disordered stretches with multivalent, low-complexity 
motifs 
114
 from the ubiquitin independent degradation pathway. 
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6. SUMMARY 
 We demonstrated that structural order does not increase in the complex of full length 
c-Fos and c-Jun, therefore the two forms a fuzzy complex. 
 We have shown that protein turnover can be modulated via fine-tuning the association 
with a binding partner. 
 We demonstrate that protection of disordered regions does not require induced 
folding, but can be achieved within a fuzzy complex of nanny and client through 
weak heterogeneous interactions. 
 The data suggest a plausible model of how post-translational modifications by 
changing the dynamics within such a complex may influence half-life. 
 Our work predicts that low-complexity dynamic regions engaging in fuzzy 
interactions may serve as selective inhibitors of proteolysis.  
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